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Abstract 
Although Raman scattering has traditionally been considered a weak process, 
making analysis of low concentration analytes in complex matrices difficult, both 
methodological and instrumentation advances in the last couple decades have made 
Raman spectroscopy a viable and useful analytical tool. This is especially true for analyte 
species within aqueous environments because the Raman scattering cross-section of 
water is small; one particular example of a critical aqueous environment is analysis of 
and in blood. The work detailed in Chapter 1 will analyze much of the literature related to 
Raman analysis in blood within the last 20 years, including normal Raman, surface-
enhanced Raman, and spatially offset Raman analyses. The first section will focus on 
direct analysis of blood samples, including determining the age of deposited or donated 
blood and blood content within body fluid mixtures. The second section will discuss 
intrinsic Raman-based detection of small molecules and protein analytes within blood as 
well as extrinsic Raman detection of tumors. The last section will review the recent use of 
spatially offset Raman and surface-enhanced spatially offset Raman spectroscopy to 
analyze molecular analytes, tissue, bone, tumors, and calcifications, including in 
vivo analysis. This focal point closes with perspective on critical gaps and upcoming 
developments for Raman analysis in blood. Raman detection in blood can be applied to 
different forensic fields and can also be used for the detection of foreign analytes.   
In current events, ricin has been discussed frequently because of letters sent to 
high-ranking government officials containing the easily extracted protein native to castor 
beans. Ricin B chain, commercially available and not dangerous when separated from the 
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A chain, enables development of ricin sensors while minimizing the hazards of working 
with a bioterror agent that does not have a known antidote.  As the risk of ricin exposure, 
common for soldiers, becomes increasingly common for civilians, there is a need for a 
rapid, real-time detection of ricin. To this end, aptamers have been used recently as an 
affinity agent to enable the detection of ricin in food products via surface-enhanced 
Raman spectroscopy (SERS) on colloidal substrates.  One goal of this work is to extend 
ricin sensing into whole human blood; this goal required application of a commonly used 
plasmonic surface, the silver film-over-nanosphere (AgFON) substrate, which offers 
SERS enhancement factors of 106 in whole human blood for up to 10 days.  This 
aptamer-conjugated AgFON platform enabled ricin B chain detection for up to 10 days in 
whole human blood.  Principle component analysis (PCA) of the SERS data clearly 
identifies the presence or absence of physiologically relevant concentrations of ricin B 
chain in blood. In addition to the detection of ricin B chain at a relevant concentration, 
the development of a platform to perform a single experiment calibration curve was 
performed through the combination of microfluidic devices with SERS substrates.  
Microfluidic sensing platforms facilitate parallel, low sample volume detection 
using various optical signal transduction mechanisms. Herein, we introduce a simple 
mixing microfluidic device, enabling serial dilution of introduced analyte solution that 
terminates in five discrete sensing elements. We demonstrate the utility of this device 
with on-chip fluorescence and surface-enhanced Raman scattering (SERS) detection of 
analytes, and we demonstrate device use both when combined with a traditional 
inflexible SERS substrate and with SERS-active nanoparticles that are directly 
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incorporated into microfluidic channels to create a flexible SERS platform. The results 
indicate, with varying sensitivities, that either flexible or inflexible devices can be easily 
used to create a calibration curve and perform a limit of detection study with a single 
experiment.  
In Chapter 4, the synthesis of an ultrastable and reversible pH nanosensor using 
gold nanosphere aggregates functionalized with 4-mercaptobenzoic acid (MBA) that are 
encapsulated in mesoporous silica was performed. The pH nanosensor is stable and 
functional in human whole blood for a period of more than 3 months.  
With the growing interest in nanoparticles and nanomaterials, a demonstration 
was organized for a high school AP Chemistry class. Spectrophotometry and colorimetry 
experiments are common in high school and college chemistry courses. Previous work 
has demonstrated that handheld camera devices can be used to quantify the concentration 
of a colored analyte in solution in place of traditional spectrophotometric or colorimetric 
equipment. Chapter 5 extends this approach to an investigation of a mesogold mineral 
supplement. With the addition of free Google applications, the investigation provides a 
feasible, sophisticated lab experience, especially for teachers with limited budgets. 
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Chapter 1. Raman Spectroscopy of Blood 
 1.1 Introduction 
Until the 1980s, Raman spectroscopy was limited in its scope for use in chemical 
analysis due to relatively low signal strength, background fluorescence, and inefficient 
light collection and detection.7 While the most common detection techniques at the time 
were based upon the use of fluorescent tags and immunoassays, Raman spectroscopy was 
still pursued because it yield direct, intrinsic information about measured analytes i.e., 
each molecule has a unique combination of molecular vibrations leading to a 
spectroscopic fingerprint.  While infrared absorption spectroscopy also reveals molecular 
characteristics, Raman spectroscopy offers a distinct advantage over infrared 
spectroscopy because it can be used to analyze aqueous solutions. The small Raman 
scattering cross-section of water (5.33!1027 cm2/molecule sr) minimizes background 
interference from the matrix, allowing analysis of bodily fluids, which are complex 
mixtures of cells, proteins, enzymes, and small molecules in water.91 
Utilizing this advantage, Raman spectroscopy has recently been employed to detect a 
myriad of analytes in biological systems, encouraging the application of Raman 
spectroscopy in biosensors. A biosensor is composed of a recognition element and a 
signal transducer. Binding of the target analyte to the recognition element generates a 
signal (e.g. electrons, light, mass effect) that is then detected by the transducer. Common 
examples of recognition elements include antibodies, enzymes, nucleic acids, aptamers, 
and other synthetic molecules. Common transducers include electrodes for 
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electrochemical sensors and CCD cameras for optical sensors.2 Employing a recognition 
element for specific binding reveals not only molecular binding, but can also sometimes 
reveal critical characteristics of the binding event. Biosensors can exploit either extrinsic 
or intrinsic detection of the target analyte.  Extrinsic detection methods, such as 
fluorescent tags, often require knowledge of the sample to be analyzed and also the 
identity of analyte that is to be detected.  In contrast, intrinsic detection can be utilized to 
help ascertain the contents of a sample when minimal information is known about the 
sample. An area of study where minimal sample information is often the case is in 
forensics.  
The use of Raman spectroscopy for forensic chemistry applications has recently 
gained popularity because of the technical advantages of the method, including the non-
destructive nature of the measurements, minimal sample quantity required, rapid analysis, 
on-site identification (with the advent of portable Raman spectrometers), and the ability 
to distinguish different bodily fluids as well as mixtures of bodily fluids.26 The most 
common bodily fluid found at crime scenes is blood, and the identification of mixtures of 
bodily fluids can be accomplished by comparing samples to a database of Raman spectra 
from bodily fluid components while at a crime scene.  To this end, analysis of the 
different components of bodily fluids and, most commonly, blood can be useful to 
ascertain the age and origin of the fluid (i.e. the difference between venous blood and 
menstrual blood).  Beyond identifying and dating blood, Raman spectroscopy can also be 
used to detect and identify analytes present in blood.  The scope of this review is to detail 
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how Raman spectroscopy is being used to identify blood, blood components, and analytes 
in blood; the review also includes analysis in body tissue because of the complexity of 
interstitial fluid for analysis.  
!"- ,./0/$,123*%&'4*'25,673&7+38,
Vibrational Raman spectroscopy is the measurement of inelastic scattering of 
light during molecular vibrations.  This phenomenon was predicted theoretically by 
Smekal in 1923, but was not observed until 1928 by Raman and Krishnan.3-5 Because 
both offer a fingerprint identity of molecular vibrations of samples, Raman and IR 
spectroscopy are similar; however, unlike IR, Raman scattering is a two-photon process.  
While the absorption of photons translates directly into vibrational energy in IR, Raman 
scattering occurs as the interaction of the electric field of the incoming light induces a 
change in the polarizability of the molecule, thereby creating an induced dipole.6  This 
virtual state of the molecule is not a true quantum state, but can be considered to be a 
very short-lived distortion of the electron cloud of the molecule by the incoming electric 
field of light.7  The radiation emitted from this induced dipole moment contains both 
Stokes and anti-Stokes Raman scattered light as well as Rayleigh scattered light.     
The drawback of Raman spectroscopy is the inherently low signal intensity; only 
one Raman scattered photon results from 1010 input photons.6,8  To overcome the low 
signal strength, many techniques have been developed, including surface-enhanced 
Raman (SERS), surface-enhanced resonant Raman spectroscopy (SERRS), coherent anti-
stokes Raman (CARS), hyper-Raman, and tip-enhanced Raman (TERS).9-12  These 
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techniques rely on modifications of traditional normal Raman scattering and the 
advancement of instrumentation, including laser technology. Herein, rather than consider 
all the technique variations used in Raman spectroscopy, we focus on the techniques that 
make analysis of blood components and analytes in blood a possibility, including normal 
Raman, SERS, spatially offset Raman spectroscopy (SORS), and the related surface-
enhanced spatially offset Raman spectroscopy (SESORS).  
Both chemical and electromagnetic mechanisms contribute to the enhancement 
seen from SERS (with typical enhancements ranging from 106-108).6,9,13  The chemical 
enhancement is predicted to provide an enhancement factor of about 100 and necessitates 
that the molecule is directly adsorbed to a noble metal surface.  In the chemical 
mechanism, a charge-transfer state is created between the adsorbate and the metal 
surface, providing a pathway for a Raman transition.  Some in the SERS community 
believe that the contributions of the chemical mechanism are minimal, especially when 
compared to electromagnetic enhancement. 
In ensemble measurements of SERS, the electromagnetic enhancement 
mechanism can be correlated with the localized surface plasmon resonance (LSPR) of a 
noble-metal substrate near Raman-active analytes.  Conduction band electrons in the 
substrate collectively oscillate upon excitation by a certain wavelength of light, 
determined by the composition, structure (size and shape), and spatial relationships of 
substrate components, generating large electromagnetic (EM) fields at the surface of the 
material.  These EM fields influence the analyte induced dipole and are capable of 
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generating enhancements on the order of 10000 or greater compared to normal Raman 
scattering by the same molecule.  Ag and Au are frequently used plasmonic substrates 
because they have convenient visible or near-infrared extinction wavelengths that match 
well with easily available lasers and detectors. 
The plasmonic properties of SERS substrates are very sensitive to nanoscale 
roughness features, and control in fabrication of nanoscale features has improved 
significantly in recent years.  A plethora of different fabricated nanostructures can be 
found in the literature including but not limited to nanparticle aggregates, on-wire 
lithography (OWLS), immobilized nanorod assemblies (INRA), and film-over-
nanospheres (FONs).14-19 Among the various substrate morphologies, there is a need to 
reproducibly fabricate substrates capable of stable performance in complex biological 
environments such as blood.   
1.3 Analysis of Blood with Traditional Methods 
Before reviewing Raman as a blood analysis tool, it will useful to first explore the 
current gold standard methods for blood analysis. Chemical analysis (both qualitative and 
quantitative) of blood is important to understand certain biological systems and for 
diagnostic purposes (including forensics).20-24 Forensic identification of blood at crime 
scenes is performed first with a presumptive test, followed by a confirmatory test.25-28  
Presumptive tests such as those performed with luminol29-32 can help to identify blood 
that is not clearly visible.  However, luminol can generate false positives.26  
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To confirm the identity of the presumed blood, a test specific to blood must be 
performed.  The simplest method to confirm the identity of blood is by identifying the red 
and white blood cells along with fibrin using a microscope.33,34 Alternative methods to 
confirm the identity of blood include scanning electron microscopy (SEM), energy 
dispersive x-ray (EDX), crystallization, UV-vis, ELISA assays, and chromatography.26  
Of these methods, the most common method is crystallization of the blood.  Of the 
crystallization techniques, the most popular are the Teichman and Takayama tests.30,33  
These tests rely on the formation of either rhombic or needle-shaped crystals under 
certain alkaline conditions;34 however, the crystal tests for blood are susceptible to under 
and over-heating of the samples and require an experienced technician to perform the test 
correctly.   
Recently, Raman spectroscopy has been utilized as a non-destructive and label-
free method to evaluate body fluids for the purposes of forensic identification.25  Raman 
spectroscopy has recently been shown to be a promising confirmatory test for blood. Both 
the Teichman and Takayama tests require a larger amount of blood than for Raman 
sampling and require modification to the sample ahead of analysis.  In addition, blood has 
a unique Raman spectrum that can be distinguished from other body fluids such as saliva, 
sweat, semen and vaginal fluid.25,27,28,35,36  Moreover, Raman facilitates the distinction 
between mixtures of body fluids and pure blood.26  
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 Table 1.1 Components in blood and components that are Raman active.  
Blood Components Concentration 
Male    Female 
Raman 
Active? Y/N 
References 
Hemoglobin*  16.3  14.5 Yes  
 
20, 26, 27, 38, 41, 
43 (Heme) (g/100 ml 
of blood) 
Phenylalanine*  Y 38 
Glucose*  Y 37 
Proerythroblasts 0-3.4 - 21 
Normoblasts 
-Early 
-Intermediate 
-Late 
 
0-20.4 
- 21 
 
0-25 
Myeloblasts 0-2.8 - 21 
Promyelocytes 1.2-6.8 - 21 
Myelocytes 
-Neutrophilic  
-Eosinophilic 
 
4.0-16.4 
- 21 
0-1.8 
Metamyelocytes 3-10 - 22 
Band cells 17-33 - 22 
Segmented cells 
-Neutrophilic 
-Eosinophilic 
-Basophilic 
 - 22 
5-25 
0-4 
0-0.5 
Lymphocytes 1.5-19.1 - 21 
Monocytes 0-4 - 22 
Megakaryocytes 0.03-3.00 - 23 
Plasma cells 0-4.1 - 21 
Reticulum cells 0.2-2.0 - 23 
Unclassified cells 0-0.5 - 24 
*Cells, % of total cell count 
 
1.4 SERS 
Blood observed after drying in the presence of Au nanoparticles shows a spectrum 
very similar to normal Raman of red blood cells: the approximate ratio of RBCs to WBCs 
to platelets is 600:1:40.41,42   In this work, the authors observed several key differences 
 
 
 8 
 
between normal Raman and SERS of RBCs. In particular, the normal Raman 
measurements exhibit bands that are not present in the SERS spectrum such as the amide 
I (1654 cm-1 shift), the CH2/CH3 amino acid deformation modes (1450 cm-1 shift), "20 
(1399 cm-1 shift), and the " Fe-O2 (568 cm-1 shift).  The peaks that appear strong in the 
SERS spectrum, but not in the normal Raman spectrum, are 1513, 551, 1471, and 496 
cm-1 shift bands.  Although the authors do not assign the new vibrational bands present in 
the SERS spectrum to particular functional groups, they do mention many red shifts of 
certain vibrational bands when comparing normal Raman to SERS spectra.  The “new” 
peaks in the SERS spectrum may possibly be attributed to vibrational modes present in 
the normal Raman spectrum, but with dramatic frequency shifts due to contact with the 
Au surface.  The authors also hypothesize that the contributions found in the SERS 
spectrum could result from cell membrane components (glycoproteins, glycolipids, 
spectrin, cholesterol, phospholipids, transmembrane proteins, etc), which would be in 
contact with the Au surface; while the size of a RBC is on the order of several microns, 
SERS enhancement arises from only within about 5 nm from the Au surface.  
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SERS analysis of human whole blood has been performed by Ziegler et al.38  
Interestingly, these researchers observed that the dominant vibrational features in the 
recorded spectra can be attributed to changes in the vibrational bands of hypoxanthine 
over the course of 24 hours when blood was adsorbed onto Au nanoparticles.   
Figure 1.1 Raman Spectrum compared to SER Spectrum of blood and blood 
components 
Hypoxanthine is the product of purine degradation in the plasma,28 and is the 
major peak observed after about 10-20 hours aging of blood.  In contrast, normal Raman 
spectra of human whole blood is dominated by oxyhemoglobin.28,39,40  The hypoxanthine 
changes in the SERS spectrum observed from whole human blood can also be measured 
from plasma alone.  The change in intensity of the hypoxanthine signal is not a linear 
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response with time; in fact, a dramatic increase in the intensity of the hypoxanthine signal 
is observed after about 15 hours of blood storage.41 It is important to note that the authors 
did not observe the same hypoxanthine peaks when the surface was incubated with only 
RBC solutions (in saline or PBS) over the course of 1 day. While these studies reveal an 
interesting time dependent change of blood over the course of 24 hours, the blood 
donations used in this work are from only 2 individuals.  Comparison of these results 
with a larger sample size would be interesting to observe the generality of these spectral 
signatures.  If generalizable, this method of evaluation could be used in forensics as a 
time marker for the age of a blood sample.43  
In addition to the peaks from hypoxanthine, peaks from uric acid can also be 
measured in blood samples.43  Bonifacio et al compared silver nanoparticles incubated 
with uric acid and silver nanoparticles incubated with filtered serum and found that the 
peaks not attributed to hypoxanthine or heme can be attributed to uric acid.43 The 
identification of the unknown peaks in blood has also shown that variations of the 
concentration of uric acid from person to person can affect the amount of uric acid 
observed.43 Variation of the uric acid concentration between males and females is 
observed based on the intensity of the 637 and 1132 cm-1 peaks. 43 However, these 
variations from person to person and gender may be used as an analytical technique to 
quickly ascertain changes in uric acid levels after treatment for certain diseased people. 43 
This person-to-person variability, however, may complicate the use of SERS forensic 
analysis of blood.  Previously envisioned experiments using blood as a forensic 
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identification of blood based on age, source, and gender need to be examined further in 
future work.   
 
Table 1.2 Observed Vibrational Bands of "Normal" (Non-SERS) Raman Spectrum of Whole 
Human Blood (Liquid Drop and Dried Blood) at 785 nm 
Observed Bandb 
(cm-1) 
Intensity Assignmenta Observed 
Bandb (cm-1) 
Intensity Assignmenta 
347d M "8 1127d, 1129e m "5 
380d W #(C$CcCd) 1173 w "30 
417 M #(Fe-O-O) 1212e m "5 + "18 
570 W "(Fe-O2) 1224 we, md "13 + "42 
621 W "12 1305e, 1311d w "21 
674e, 677d M "7 1338e, 1341 m "41 
716 W %11 1374d, 1377e md, vwe "4 
754 S "15 1398 m "20 
788 W "6 1450 s #(CH2/CH3) 
825e W %10 1523e m "38 
856 W  1545e s "11 
900 W p:C-C skeletal 1563 s "19 
937 M "46 1582 m "37 
1003 S phenylalanine 1605e, 1603d m "(Ca=Cb) 
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1030 W #(=CbH2)asym 1621 s "(Ca=Cb) 
1054 W #(=CbH2)asym 1638 md, we "10 
1115e W  1654 w amide I 
  
Table adapted from Premasiri, W. R.,  Ziegler, L. D., J Phys Chem B, 2012, 116, 9376. Table 
key: protein (p) C!b, C", and Cm (carbon atoms at the alpha, beta, and meso positions of 
porphyrins, respectively); Ca and Cb (vinyl group carbons). bEstimated person ±1 cm-1. 
dDried blood sample. eLiquid blood sample.  
  
Additional challenges to Raman detection of blood and blood components for 
forensic use is NIR laser excitation of dried human blood produces heme aggregates, 
thereby shifting porphyrin ring vibrational bands by several wavenumbers.44 Once 
blood is removed from the biological system and is stored, many denaturation 
products are observed in the spectrum.  One denaturation product is reported to be 
methemoglobin and can be observed with intense laser powers or with blood that has 
been stored.44 The vibrational signature of dried blood can be attributed to a single 
protein, hemoglobin.  Previously reported vibrational bands arising from fibrin were 
found to be present because of hemoglobin aggregates and not from fibrin.  While the 
auto-oxidation of hemoglobin occurs in ambient conditions outside of the body, it is 
feasible to use this aging process to determine the age of the dried blood at crime 
scenes. 
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1.5 Analyte detection in Blood via Raman spectroscopy 
Monitoring blood composition for early diagnosis of disease is essential for 
human health. One of the paramount interests in the field of clinical analysis is to 
improve the detection of analytes in blood. Due to the many components present in 
human whole blood, detection of specific analytes may be difficult.    This section will 
include review of the literature pertaining to Raman detection of analytes in body fluids 
and offer insights into future directions.  
There are many portable devices for blood testing, such as the home glucose level 
monitor, which is based on the oxidation of glucose by an enzyme and electrochemical 
detection of a reaction byproduct (H2O2). Other blood tests (for analytes other than 
glucose), in general, require a relatively large amount of blood (5-10 mL per sample for 
conventional blood tests) and use medical lab equipment, thereby increasing the cost and 
time of analysis. Moreover, it is difficult to monitor analytes in blood continuously using 
current detection methods. 
Blood is a complex matrix. Although, water has minimal Raman absorption,45 
there is significant fluorescence background interference from other blood components.  
Gerd et al. used a near-infrared laser for excitation to minimize the fluorescence 
background.46 The fluorescence background of blood serum was also less intense when 
excited with a 785 nm laser beam compared to the visible excitation light.47-49  
Raman bands are much narrower than fluorescence bands, therefore it is possible to 
identify sharp and distinct Raman peaks even in the presence of a broad florescence 
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background without pre-treatment of blood.  Firdous et al. used Raman for direct, in vitro 
assessement of human blood glucose levels; they compared the Raman blood serum 
spectra of normal, healthy diabetic, and diabetic patients with other malignancies like 
cancer and hepatitis, and revealed a reliable glucose signature in all cases.54 The 
fluorescence and Raman signatures of proteins, lipids and other tissue content were 
present in the spectra. The featured peaks of glucose that appeared at 1168, 1463, 1531 
cm-1 shift differentiated the diabetic patients from healthy diabetic patients.  However, the 
fat adsorption and interactions with other blood components reduced the optical 
absorption of glucose, making accurate prediction of the blood glucose concentration 
impossible by this method. 
 
1.6 Analyte detection in Blood by SERS 
Amplification of the Raman signal of analytes in highly light scattering and absorbing 
media is required to improve the quality of detection. In an attempt to amplify the target 
signal via SERS, various noble metal substrates have been introduced into blood samples 
to detect various bloodborne analytes. For example, Wang et al. utilized the hotspots 
generated from Au nanorods (AuNR)-Au nanoparticle (AuNP) assemblies to detect 
thrombin in diluted human blood serum (5% human blood serum).55 AuNRs were 
modified with anti-thrombin antibodies, and AuNPs were functionalized with both a 
thrombin-binding aptamer (TBA) and a Raman reporter (mercaptobenzoic acid, MBA).  
A sandwich structure of AuNR-antibody-thrombin-aptamer-AuNPs was formed in the 
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presence of thrombin. The AuNR–AuNP junctions generated strong electromagnetic 
fields, and the localized Raman reporters in this field produced an enhanced Raman 
signal.  Using this method, subnanomolar (as 887 pM) thrombin was detected in diluted 
human blood serum. The need for diluted blood serum and added nanostructures clearly 
indicates further method development would have to be done before this method could be 
used in vivo. In another example, Yuen et al. reported low-concentration detection of 
paclitaxel, an anti-cancer drug, in blood plasma using polystyrene beads coated with 
Au.51 Using SERS, the concentration of paclitaxel was determined based on the intensity 
of the characteristic Raman peak of paclitaxel at 1605 cm-1 shift (due to C=C stretching 
mode) to an accuracy of 3.8!10&9 M (root mean squared error of prediction, RMSEP) 
within the range of 1.0!10&8 to 1.0!10&7 M. Also, Ross et al. detected a synthetic pterin 
analogue in mouse serum.56 Pteridines, aromatic heterocyclic molecules, play a key role 
in enzymatic pathways for the production of neuorotransmitters such as dopamine, 
serotonin, and epinephrine.56 Au nanoparticles mixed were used to determine the pterin 
signals in solution in mouse serum were similar to the standard solution (prepared in 
water at a concentration of 1!10-8), only with reduced signal intensity  
When the target analyte has a resonance Raman signature,40 it is possible to do in 
situ detection of analytes without any blood pretreatment. For example, Casella et al. 
reported using colloidal AgNPs as the substrate to detect beta-carotene and hemoglobin 
detection in whole blood.57 Two excitation wavelengths, 514 and 785 nm, were used in 
acquiring Raman spectra of the samples. The spectral features of proteins were minimal 
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in the Raman spectrum recorded with 514 nm excitation, but were very intense with 785 
nm excitation. Conversely, the signal of $-carotene was missing entirely in the Raman 
spectrum that was recorded with 785 nm excitation, but was present when excited by the 
514 nm laser (Figure 1.4a).   The resonance effects selectively enhance the Raman signals 
of $-carotene while Raman scattering from the blood components is comparatively weak 
when the excitation wavelength was 514 nm, which is very close to the absorption 
maximum in the UV-vis electronic spectrum of $-carotene. The normal Raman and SERS 
spectra of whole blood via 514 nm excitation are compared in Figure 2b. Although the 
excitation wavelength lies within the resonance range of $-carotene, the SERS spectra 
displayed more defined protein peaks rather than those of $-carotene. 
 
!"
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Figure 1.2. (a) Raman spectra of human whole blood excited by 514 and 785 nm laser. 
(b) Normal Raman spectrum and SERS spectrum of whole blood at 514 nm excitation. 
 
The scattering and absorption by tissue limits excitation laser penetration depth 
and optical imaging in vivo. However, some strides have been made using SERS with 
well-chosen LSPRs. For example, Qian et al injected AuNPs with covalently bound 
Raman reporters into subcutaneous and deep muscular sites in live animals.58 In vivo 
SERS spectra were obtained by focusing a 785 nm laser at the injection spots. After 
background subtraction, the obtained SERS spectral features, though lower in intensity, 
#"
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were identical to the in vitro spectra. For in vivo SERS detection, the maximum depth of 
visualization reported to date is 1-2 cm.   
Qian et al utilized PEGylated AuNPs for in vivo tumor detection in live animals. 
The thiolated PEG did not displace the Raman reporters (crystal violet, Nile blue, basic 
fuchsin and cresyl violet) that adsorbed on the surface of the AuNPs by electrostatic 
interaction and protected the Raman reporters from harsh conditions including acids, 
bases, high ionic strength and organic solvents. The targeting ligand on the AuNPs was a 
ScFv antibody, which can recognize the epidermal growth factor (EGFR) that is 
overexpressed in many types of tumor cells. They also found that the AuNPs provided 
much stronger emission intensity than quantum dots under the same experimental 
conditions. 
Another way to minimize the background noise of blood is to extract the 
interested analytes from the blood. Gerd et al. detected various commonly applied drugs 
including codeine, dihydrocodeine, pipamperone, doxepine, citalopram, trimipramine, 
doxylamine, carbamazepine, and methadone in blood and urine by using the combination 
of high-performance liquid chromatography (HPLC) and SERS. The body fluids were 
first mixed with ethylacetate to extract the drugs into the oil layer. Since the extractions 
of the drugs of interest were not perfect, HPLC was performed on the extract to separate 
the mixture. HPLC analysis required at least 8 min for each separation of analytes at 
5!10&8 M50,51 and is not capable of identifying the analytes without a separate detection 
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method. The detection method used for this study was SERS because of its sensitivity 
and ability to distinguish structurally similar compounds. 
Alternatively, if an analyte of interest is known then substrates can be 
functionalized to selectively extract the target. For example, Liu et al. used a SERS active 
substrate composed of Ag nanoparticles on arrays of anodic aluminum oxide (AAO) 
nanochannels functionalize with vancomycin, which can form hydrogen bonds with 
bacterial cell walls.52 The bacteria were captured from blood and washed with water 5 
times before SERS analysis. This allowed the group to efficiently remove the bacteria 
from the interfering media for analysis. 
Reduction of the background of blood can also be achieved by simply removing 
the red blood cells and macromolecules. Hsu et al. applied silver colloidal nanoparticle-
mediated SERS for rapid identification and quantification of lactic acid in human blood.53 
To reduce the background interference and improve the SERS resolution, the whole 
blood was first centrifuged to obtain serum and then ultrafiltration was applied to remove 
macromolecules from the blood. They achieved impressive accuracy of measuring lactic 
acid at the low physiological concentration of 0.55 mM. 
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Figure 1.3.  Photos of a live mouse with a AuNP injection. The laser beam is focusing on 
the tumor site and liver for SERS detection. 
Developing Raman spectroscopy for sensing in blood has remained an elusive 
target. Although the application of Raman spectroscopy is still rare, these studies have 
demonstrated the utility of Raman spectroscopy for analyte detection in complex 
biological media. Achievement of accurate and detailed measurements of analytes for 
clinical usage requires the optimization of our techniques, specifically, amplification of 
signal intensity via SERS and the development of higher efficiency capture and target 
ligands. 
!"G ,16.1H1C16.1H?&/$40+44+'$,./0/$,
As previously mentioned, bio-media are highly heterogeneous and light 
scattering59,60 making them extremely difficult to be analyzed by optical methods. 
Conventional Raman spectroscopy collects the photons scattered from the surface of a 
sample and is able to achieve information typically extending no more than a few 
millimeters into the sample due to the shallow penetration depth of the photons collected 
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in this way. Moreover, since the illumination and collection zones coincide, conventional 
Raman spectroscopy would also collect significant amount of fluorescence signal 
generated by the complex media leading to massive background noises.  However, it is 
possible to utilize a modified Raman Spectroscopy technique, spatially offset Raman 
spectroscopy (SORS) to analyze the composition of the complex media and its 
components. 
SORS is a technique that has been demonstrated to obtain Raman spectra from 
deeper layers of the sample and suppress fluorescence background.61,62 Instead of 
collecting the photons directly from the backscattered light, SORS relies on the photons 
that emerge from positions that are spatially offset from the illumination spot. The 
photons that penetrate into the samples are scattered. As they propagate through a 
diffusely scattering media, the majority of the photons will be backscattered rapidly. 
Those photons not backscattered initially will diffuse through the media and emerge 
several centimeters away from the position of the incident laser. Consequently, the deeper 
the photons penetrate, the further they are emitted from the launch spot. The spectra 
acquired at different distances from the center point can provide details about the 
composition of the sample at different depths.  
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Figure 1.4. Normal Raman spectroscopy versus spatially offset Raman spectroscopy. 
The scheme shows the conventional backscattering Raman spectroscopy (left) and Spatial 
Offset Raman Spectroscopy (SORS, right). L stands for Laser and R stands for Raman. 
'S is the spatial offset.  
Increasing the depth of penetration results in a wider distribution of photon 
emitting locations and significant attenuation of the intensity when photons diffuse 
through the media. Because a lower proportion of the incident photons reach farther 
depths, the resolution of SORS is quite limited. Usually, a set of SORS spectra are 
collected with ring fiber probes that are connected to different CCDs; Results vary 
between each individual CCD.63 Distortion of post-processed SORS spectra also lowers 
the detection resolution of SORS.  
The idea of inverse-SORS was introduced by Matousek64 and Schulmerich et al.65 
They proposed that instead of illuminating the laser source in one spot and collecting the 
 
 
 23 
 
spectra in a circle of a given radius, the fiber probes could be located at the center while 
the laser beam was supplied in a ring shape centered at the collection spot. The spatial 
offset can be simply accomplished by changing the radius of the laser ring. Since the 
excitation laser is spread over a larger area compared to point laser excitation, higher 
laser power would be used while maintaining the power density under the threshold of 
biological safety. Inverse-SORS shows significant improvement in the detection limit.  
 
 
Figure 1.5. SORS variation of delta S based on the depth of penetration of the photons 
(upper-left) and inverse SORS (lower-right). Comparison of SORS and inverse SORS. 
delta S1 and delta S2 are spatial offsets of Raman scattering from different depths of the 
sample. 
Transmission Raman spectroscopy is considered as a special case of SORS 
(Figure 1.3).64 Instead of collecting photons from the incident surface, the photons that 
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pass through the sample are collected on the opposite side of the sample and therefore the 
overall bulk sample information is obtained by transmission Raman spectroscopy. 
 
 
Figure 1.6. Diagram of SORS (left) and transmission Raman (right). 
Current non-invasive clinical screening methods are unable to provide accurate 
and detailed chemical information of tissue components, such as veins, bones and other 
subsurface tissues. Because of the ability to analyze samples at different depths, SORS 
can be used in detecting analytes in concealed containers,66 e.g., identifying the 
composition of encapsulated medicine or differences in tissue composition in vivo.67  
Successful attempts to screen analytes in plastic containers, the properties of non-invasive 
detection, clinically relevant detection depths, and low laser power density, permit the 
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application of SORS for in vivo monitoring of the chemical compositions of living 
tissues.68,69 
Thus far, the bio-probing properties of SORS in and through bones and breast 
tissues have been investigated. Matousek et al70 demonstrated the feasibility of SORS to 
obtain in vivo Raman spectra from human bones. The spectra were collected by ring fiber 
probe with zero and 3 mm spatially offset and acquired using a 2 mW laser beam for 200 
seconds- far below the threshold for skin safety. The skin tissue signals and the 
fluorescence background were effectively minimized by the subtraction of spectra from 
the zero- offset spectra. Despite low-quality processed bone spectra, the results 
demonstrate a proof-of-concept trial requiring further research on the topic of SORS bone 
diagnosis.  
Probing through soft tissues is more challenging than the flat and relatively simple 
composition of bones. Researchers have devoted significant effort towards developing 
techniques to diagnose breast cancer via SORS. The similarity between tumors and other 
soft tissue make distinguishing between them difficult. Keller et al. first demonstrated the 
possibility of discerning cancer tissue beneath as much as 2 millimeters of normal breast 
tissue.71   Later, they developed a Monte Carlo code, which predicts the photon 
propagation, to evaluate the SORS performance in soft tissue.72 Combining their 
numerical simulation and multi-separation SORS probe improved the sensitivity of the 
tumor signatures.73  
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Aside from direct detection of tumors using Raman spectroscopy, breast cancer 
may also be diagnosed by analyzing the calcification induced by benign tumors. The 
research of Holme et al.74  demonstrated the relation between microcalcification and 
tumor metastasis. Different compositions of calcification deposits reflect the level and 
location of tumor cells.75,76  Accurate diagnosis of breast cancer is possible by analysis of 
calcium deposits using SORS. Stone et al. demonstrated the feasibility of SORS to 
distinguish different calcification types through chicken breast and skin.77 Note, the 
above two groups both used chicken breast as a sample tissue. However, chicken breast 
does not fully represent human breast tissue. Therefore, in vivo detection of breast cancer 
cells in human by SORS remains a challenge. 
Surface-enhanced spatially offset Raman spectroscopy (SESORS) is a new 
methodology that combines SORS with SERS to accomplish deeper probe depth and 
higher detection sensitivity. The feasibility of SESORS was first introduced78  and 
demonstrated by the Matousek group; they recovered the Raman signal from a 20 mm 
thick porcine tissue using a combination of signal enhancement from injected SERS 
active nanoparticles and transmission Raman spectroscopy.79 The Van Duyne group 
expanded the applications of SESOR to include in vivo glucose sensing51,80 and imaging 
through bones.81 A silver film-over-nanosphere (AgFON) substrate functionalized with 
decanethiol (DT), and 6-mercapto-1-hexanol (MH) was implanted beneath the skin of 
rats. The transcutaneous glucose concentration was controlled by intravenous infusion of 
glucose or insulin. The SESORS measurements of glucose in the blood of a rat were 
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consistent with the readings from a home glucose level reader and achieved a successful 
17-day continuous monitoring of glucose levels.  
The detection of Raman reporter tagged nanoparticles through bones via SESORS 
was recently reported by the Van Duyne group. Silica coated 90 nm gold cores with 
trans-1,2-bis(4-pyridyl)- ethylene (BPE) as the Raman reporter were injected into the 
tissues adjacent to an ovine shoulder bone. Due to the surface plasmon enhancement, the 
Raman signal of BPE was detected through the bone with a maximum thickness of 8 mm. 
The authors propose using SESORS detection for in vivo detection of analytes in human 
brain tissue (with average skull thicknesses ranging from 3-8 mm). The prospects for 
SORS as an efficient non-invasive medical imaging and analysis tool remain promising; 
despite no reports of using SORS for blood analysis, it still has enormous potential for in 
vivo blood detection through skin tissue and veins.   
1.8 Analysis of other bodily fluids 
Recent work on SERS biosensing has resulted in extensive literature focused on 
applications in human blood plasma, seminal plasma, whole blood, and interstitial fluid. 
Low-level detection of several medicinal compounds has been achieved using SERS on 
blood plasma samples including the detection of apomorphine, used in treating 
Parkinson’s disease, by adding silver colloid to a plasma sample following thin layer 
chromatography.82 SERS immunosensors have been used in blood plasma by Li et al., to 
detect human immunoglobulin G (IgG) and the vascular endothelial growth factor, a 
biomarker for tumor angiogenesis. Using Au@Raman reporter@SiO2 nanoparticles 
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coupled with a gold triangle nanoarray, a sandwich-assay was constructed with a reported 
limit of detection of 7 fg/mL IgG.83   
Without a focus on specific biomarkers, computational methods for processing 
data can also help enhance and distinguish spectral features. For example, principle 
component analysis (PCA) of SERS spectra has been used in conjunction with membrane 
electrophoresis to analyze and distinguish blood plasma of healthy patients from patients 
with gastric cancer.84 Zeng and coworkers have also combined PCA with linear 
discriminant analysis in the detection of nasopharyngeal, gastric, and cervical cancers 
from blood plasma samples.85-87 This technique has been applied to seminal plasma, 
using polarized SERS to analyze semen quality.88   
1.9 Future directions 
There are many current methods that can be applied for the detection of components 
already present in blood such as handheld glucose monitors.  Two branches of future 
technology include the detection of foreign analytes such as bacterial infections without 
the need for culturing the bacteria and blood diagnosis without the need for drawing 
blood.  Culturing bacteria is often time consuming and treatment is delayed until the 
amount of live cultures can be assessed and analyzed facilitating the need for broad-
spectrum antibiotics given to the patient. To give an example of these applications of 
SERS to human whole blood, two recent methods for the identification of bacteria in 
blood samples are:  bimetallic silver-gold SERS surfaces were used by Sivanesan et al. 
with antibiotic coatings to selectively capture and identify E. coli, S. enterica, and S. 
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epidermidis;89 and Yang and coworkers utilized a microfluidic platform and 
electrokinetic concentration to rapidly identify S. aureus, E. coli, and P. aeurignosa.90   
Examples of blood diagnosis without the need for drawing blood have been 
mentioned previously thru the use of SESORS, these nanoparticles were functionalized 
with a widely used Raman reporter.  In order to expand the technology towards the 
analysis of common blood tests such as glucose monitoring, cholesterol measurements, 
and other biomarkers there is a need to develop stable and sensitive nanoparticles able to 
withstand the blood environment while being able to remain in tact long enough to 
conduct measurements and biocompatible as to not cause harm to the patient.  
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Chapter 2. Surface-Enhanced Raman Spectroscopy Detection of Ricin B 
Chain in Human Blood 
2.1 Introduction    
Ricin is a naturally occurring toxin that is found in the castor bean to protect the 
plant from pests. The detailed protein structure and the mechanism of its toxicity have 
been extensively and thoroughly studied over the last two decades.1-3 This globular 
protein is comprised of two chains linked by a single disulfide bond.4 Ricin A chain is the 
ribosome-inactivating toxin that inhibits protein synthesis, while ricin B chain is a lectin 
that attaches to galactose residues on the cell surface facilitating entry.5 Both chains are 
necessary for in vivo toxicity. 1,6-10 Once the protein translocates into a cell’s cytosol, one 
molecule of ricin is sufficient to kill that cell. The median lethal dose (LD50) of crude 
ricin in mice is 8 µg/kg by injection and 10 µg/kg by inhalation.11,12 After exposure to a 
lethal dose of ricin, the time to death is typically 60-90 hours.13 The relative ease of 
extraction and isolation of ricin, combined with the ubiquitous presence of the castor 
plant, make ricin an easily obtainable and frequently used bioterror agent. Ricin is 
considered the third-most toxic substance due to its toxicity and abundance according to 
the U.S. Environmental Protection Agency and the Center for Defense Information.14-17 
Thus, rapid and easy-to-apply diagnosis of ricin infection in a bio-matrix like whole 
human blood remains a priority. Many methods have been developed to detect ricin in 
various media, including mass spectrometry, cell culture assays, and immunochemical 
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assays.18,19 Most of the methods to detect ricin can be confounded by complex biological 
environments and a lack of accuracy. Enzyme-linked immunosorbent assays (ELISA) are 
the current commercial method in ricin detection. By using an antibody, ELISA is able to 
detect ricin selectively and sensitively. However, the antibody is expensive and sensitive 
to the environment, and non-specific interactions with other proteins or molecules and 
large variance also limits the application of this method in complex matrices. 
Aptamers are short single DNA or RNA strands that, like antibodies, have 
specific affinity to analytes ranging from small inorganic molecules to proteins or even 
whole cells.20,21 Aptamers show many advantages in the analytical detection applications 
competing with traditional antibody-based methods. In contrast to antibodies, aptamers 
are easily synthesized in high purity and modified with desired functional groups. Unlike 
antibodies, aptamers are more stable at various conditions and can reversibly fold and 
unfold. 
Sreevatsan et al. selected an aptamer specific to ricin B chain (RBC) from a 
combinatorial oligonucleotide library by systematic evolution of ligands by exponential 
enrichment (SELEX).22,23 This RBC aptamer is a 40-mer (5’- 
ACACCCACCGCAGGCAGACGCAACGCCTCGGAGACTAGCC-3’) that contains a 
bulge loop and a hairpin loop, and it is thermally stable from 4-63 °C. The thiolated RBC 
aptamer used in the experiments presented herein were heated up to 95 °C for 5 minutes 
to fully unfold the hairpin structure and submerged in ice water to fold the aptamer into 
the most stable conformation prior to the modification of the substrate. Previous work 
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with this aptamer showed that it is able to detect 30 ng/mL of RBC from several liquid 
food matrices.22-24 The authors also demonstrated that the RBC aptamer was capable of 
detecting intact ricin (even though it was developed using only ricin B chain) and 
demonstrated 
that this aptamer 
sequence had a 
binding constant 
better than other 
reported ricin 
aptamers and 
comparable to 
the current 
commercial 
ELISA 
antibodies. 
Upon 
binding to the 
target analyte, 
the conformational change of aptamers can be detected by various optical analysis 
methods. The Labuza group reported the use of the RBC aptamer and surface-enhanced 
Raman spectroscopy (SERS) to detect ricin in food matrices.23 Because the Raman 
  
Figure 2.1. SERS on a AgFON of (a) ricin B chain aptamer (b) 
ricin B chain aptamer in blood and (c) ricin B chain aptamer in 
blood spiked with 1 µg/mL of ricin B chain. Spectra are vertically 
offset for clarity, %ex  = 633 nm.  Each trace is the average of 7 
randomly chosen spots on the AgFON.  
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scattering cross-section of water is very small, SERS is a promising label-free detection 
method for analyte detection in aqueous environments, including both food matrices and 
blood.25,26 Especially, when one needs immediate detection, SERS as an optical analysis 
method shows a distinct time advantage over the conventional methods that would 
require culturing cells prior to detection. An additional advantage of using the aptamer 
affinity agent is that aptamers are small compared to antibodies, meaning that captured 
analytes are more likely to be detected by SERS, where signal exponentially decays with 
the distance between the analyte and the noble metal surface.  
To efficiently detect and monitor ricin in the human body, it is desirable to 
capture and detect ricin directly in whole human blood; however, this is likely to be 
challenging based on the biological complexity of blood. Several research groups have 
successfully used SERS to detect analytes in simpler body fluids. For example, Ridente et 
al detected trace amount of amphotericin B, a drug for fungal infections in dilute plasma, 
via surface-enhanced resonance Raman spectroscopy in dilute plasma.27,28 Also, Trachta 
et al combined the techniques of SERS and HPLC to detect codeine and carbazepine in 
human blood and urine.29 Recently, several groups have reported SERS measurements in 
whole human blood. Liu et al utilized a vancomycin-coated SERS substrate to capture 
and detect bacteria from human blood without interference from blood cells.19 Casella et 
al were able to recognize and assign the fundamental features of !-carotene and the blood 
protein hemoglobin in human blood by SERS.30 Wang et al and Sha et al both reported 
the detection of circulating tumor cells in blood, relying on AuNPs conjugated with a 
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Raman-active tag.31,32 Herein, ricin B chain captured by the aptamer-modified AuFON is 
directly detected by SERS in whole human blood. This study also includes consideration 
of the reversibility of binding between ricin B chain and the aptamer-modified SERS 
substrates. While the detection of RBC is exciting, this general approach could easily be 
adapted to detect other bloodborne protein targets. 
 
2.2 Experimental: 
2.2.1 SERS Substrates:Ag Film-over-Nanospheres 
Silver film-over-nanospheres (AgFON) substrates were fabricated as has been 
previously reported.33,34 Briefly, a silicon wafer was cleaned with a water:ammonium 
hydroxide: 30% hydrogen peroxide (10:1:1) mixture under sonication for 60 minutes.  
The wafers were thoroughly rinsed with water followed by silica microsphere (Thermo 
Scientific, Waltham, MA) drop coating.  Typically, 1-10 µL of the silica microsphere 
solution was drop cast onto the wafer followed by gentle agitation/mixing and allowed to 
air dry.  Silver metal (200 nm thick, 99.999% Ag Kurt J Lesker, Clairton, PA) was 
deposited with a vacuum evaporation chamber (Denton Vacuum, Moorestown, NJ) 
equipped with a quartz crystal microbalance.  Ahead of aptamer modification, freshly 
fabricated AgFONs were plasma cleaned using argon gas for 4-6 minutes in a plasma 
chamber.35 Then, 10-40 µM ricin B chain aptamer solution (5’ACA CCC ACC GCA 
GGC AGA CGC AAC GCC TCG GAG ACT AGC C3’ dithiol spacer, Integrated DNA 
Technologies, Coralville, IA) was added to the plasma-cleaned AgFONs  and incubated 
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at 4 °C overnight followed by rinsing with nuclease-free (Integrated DNA Technologies) 
water.  The functionalized-AgFONs were then dried with a gentle stream of nitrogen gas.   
2.2.2 Ricin B Chain Incubation Experiments 
Individual AgFONs functionalized with the aptamer were incubated in either 
nuclease-free water, buffer, or whole human blood. The solution was then spiked with a 
known concentration of ricin B chain (Vector Laboratories, Burlingame, CA) and gently 
mixed by swirling.  Following the defined incubation time, the AgFON was removed 
from the solution and rinsed with copious amounts of nuclease-free water.  The AgFON 
was then dried with nitrogen gas ahead of SERS interrogation. 
2.2.3 Surface-enhanced Raman Spectroscopy Measurements  
Raman spectra were acquired using a 632.8 nm HeNe excitation laser (Research 
Electro-Optics, Inc, Boulder, Colorado) that passed through an interference filter (Melles-
Griot, Rochester, NY) ahead of direction to the sample using an aluminum-coated prism 
(final laser spot size on the sample was 1.26 mm2).  The Raman scattered light was 
focused using a 50 mm-diameter achromatic lens (Nikon, Melville, NY), and the 
Rayleigh scattered light was rejected with a notch filter (Semrock, Rochester, NY).  A 0.5 
m SpectraPro 2500i single monochromator equipped with a Spec400B liquid nitrogen-
cooled CCD (Princeton Instruments/Acton, Trenton, NJ) was used to collect and measure 
the Raman scattered light.  The CCD was calibrated using the emission wavelengths of a 
Neon lamp.   
2.2.4 Principal Component Analysis of SERS Data 
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Principal component analysis  (PCA) has recently found use as a chemometric 
tool capable of removing the fluorescence background from Raman spectra as well the 
discrimination of the Raman spectra of pathogenic bacteria and paint pigments. 36-40 PCA 
is a statistical technique that reduces the dimensionality of a spectral dataset. It achieves 
this by reducing the dataset to a linear combination of orthogonal vectors in a way such 
that a majority of the variance between spectra is explained by the first vector. The dot 
product of the first vector with any spectrum gives the value of that spectrum’s first 
principal component. The projection of the second vector (which explains the second 
most variance) gives the second principal component. Due to the variability in signal 
from SERS (due to subtle variations in laser power and substrate uniformity), PCA often 
does not discriminate well based on raw SERS spectra. Patel et al have proposed the use 
of the magnitude of the second derivative of the spectra as input to PCA.40 Here, we 
remove cosmic rays from our spectra, followed by removing the baseline by subtracting a 
wide (500 cm-1) Hamming Window from each spectrum, followed by normalization, a 
spline interpolation of the data onto a 1 cm-1 grid, and finally perform PCA analysis on 
the sign (+/-) of the second derivative of the dataset. 
2.2.5 Thermal and Ionic Strength Stability Assessment  
All of the stability experiments were performed with both benzenethiol (a standard high 
scattering cross-section Raman scatterer) and RBC captured on the AgFONs. In the 
thermal stability tests, the AgFONs, following analyte incubation, were placed in 2 mL of 
nuclease-free water at various temperatures ranging from 70 °C to 95 °C for either 30 
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seconds or 5 minutes. The AgFONs were then rinsed with 1 mL of nuclease-free water to 
remove any free analyte after the thermal treatment. The SER spectra were then measured 
from N2  gas-dried AgFONs using the same experimental apparatus described above. 
While elevated temperature is one possible way to compromise aptamer or protein 
stability, variations in ionic strength may have a similar effect by weakening electrostatic 
or H-bonding interactions.  Herein, a 1M NaCl solution was utilized as a high ionic 
strength solution. Similar to the thermal stability tests, the AgFONs with bound analyte 
were immersed in 2 mL of NaCl solution for either 30 s or 5 min. The resulting AgFONs 
were then rinsed with nuclease-free water and SER spectra were measured. 
Possible destabilization due to pH variation was also assessed. Dilute aqueous 
HCl with pH of 4.96 and dilute aqueous NaOH with pH of 7.99 were prepared. Similar to 
the previous stability tests, AgFONs with bound analyte were immersed in 2 mL of either 
solution for either 30 s or 5 min. After rinsing, SER spectra were measured. 
 2.2.6 Computational Modeling of Aptamer on a Ag Surface 
 Quantum chemistry calculations were carried out for geometry optimization of the 
aptamer on the SERS substrate by using B3LYP.41-43 For C, H, N, and O atoms, the basis 
sets used were 6-311+G(d,f).44,45 The polarizable continuum model was used to consider 
the influence of water.26,46-49 On the basis of the optimized structures, the vibrational 
frequencies and Raman intensity were obtained. All calculations were performed with Q-
chem 4.1.0.50 
2.3 Results and Discussion 
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While single-stranded DNA has been used frequently on metal surfaces as 
reported in the literature, the use of this ssDNA in complex matrices (such as food or 
body fluids) is not widely reported due to likely interference from proteins, native DNA, 
or possible degradation of the DNA by nucleases.51-55 Freshly prepared AgFONs were 
modified with nuclease-resistant ricin B chain aptamers then incubated with 20 µg/mL 
RBC solution. The SERS of the AgFON before and after the introduction of RBC were 
collected. The RBC aptamer is 7 nm in length. Although it is hard to prove the orientation 
of the RBC aptamer on the surface of the AgFON, there was a great chance that we 
would not be able to directly detect SERS of the protein because of the exponential decay 
of the electromagnetic field with the distance from the noble metal. Figures 2.1, 2.3, 2.4, 
and 2.7 show a typical RBC aptamer and RBC captured aptamer SERS on the AgFON.  
Figure 2.1 (bottom) shows the SERS spectrum of the ricin B chain DNA aptamer bound 
to the AgFON surface.  The dominant peaks in the spectrum are the ring breathing modes 
of adenine (735 cm-1 shift) and guanine (793 cm-1 shift).52 The peak locations correspond 
well to adenine and guanine Raman spectra reported in the literature.52 After the aptamer-
functionalized AgFON was exposed to whole human blood, the aptamer SERS spectral 
peaks broaden and the signal-to-noise decreases.  The broadening may be attributable to a 
hypoxanthine scattering contribution near the observed 735 cm-1 shift peak or non-
specific adsorption of albumin to the surface of the AgFON.27,56  The decreased signal-to-
noise ratio may be caused by native blood proteins non-specifically adsorbing to the 
AgFON-aptamer conjugate, contributing either Raman scatter or background 
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fluorescence. After exposure to 1 µg/ml  ricin B chain, new spectral features are apparent 
at 640 cm-1 shift and 937 cm-1 shift; these peaks may be due to either Raman scatter from 
the protein or possible conformational change of the aptamer after a binding event. The 
nature of the binding of 
aptamers to ricin have been 
explored in other publications, 
and it has been shown that 
these aptamers may bind to 
various sites on ricin.2,3 
Identifying the exact binding 
interaction of this aptamer is 
difficult and not critical to 
achieve the purpose of this 
study.  In fact, the spectral 
changes of the aptamer-ricin B 
chain interaction remain 
consistent over many 
measured spectra on multiple 
AgFONs, making these spectral changes potential predictors of ricin B chain 
concentration.  While this initial study proved promising, our overarching goal was to be 
 
Figure 2.2. SERS of benzenethiol on a AgFON in 
human blood for (a) 0 days, (b) 3 days, and (c) 10 
days. Each trace is an average of 7 spectra acquired 
from 7 randomly selected spots.  Spectra are 
artificially offset for clarity. 
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able to detect ricin B chain in whole human blood over multiple days without any decline 
in performance of the AgFONs or the aptamer affinity agent.         
To accomplish multi-day stability of the AgFONs in human whole blood, a study 
was initiated with a standard SERS reporter molecule (benzenethiol) rather than the more 
expensive aptamer/protein combination.  Stability of AgFONs in whole human blood has 
not been previous been presented in the literature.  To ensure that a SERS-active surface 
would be stable for an extended period of time in blood, the AgFON was functionalized 
with benzenethiol (1 mM in ethanol, overnight, Figure 2.2).  A spectrum of the 
functionalized surface was acquired followed by incubation in blood.  Spectra were 
acquired after incubation in blood for 3 and 10 days after copious rinsing with water.  It 
should be noted that the AgFONs that were exposed to blood experienced significant 
degradation due to delamination of the Ag surface if care was not taken to rinse gently.  
After all the spectra were collected, a benezenethiol enhancement factor (EF) calculation 
was performed for the 0, 3, and 10 day exposure to blood, and the EFs for all 3 
timepoints remain in the 106 range.  This suggests that the roughened metal surface 
required for high EF SERS has not diminished after 10 day incubation in blood.  While 
the AgFON performance itself does not diminish after many days in blood, the 
subsequent experiment incubating a AgFON functionalized with an aptamer was not 
successful.  The 735 and 793 cm-1 shift peaks from adenine and guanine, respectively, 
were no longer present after 1 day.  The spectral decline was likely due to nuclease 
degradation of the single-stranded DNA aptamer. Following literature precedent, we 
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considered various modifications to the DNA backbone and to the DNA bases to prevent 
binding of nuclease and therefore, increase the lifetime of the DNA in biological 
solutions.57-59 The modification that was chosen was a phosphorothioate bond in the 
DNA backbone to decrease recognition of the nuclease binding sites while maintaining 
the aptamer sequence. 58,60 The aptamer-ricin B chain binding experiments were repeated 
with the nuclease-resistant aptamer after substrate exposure to whole human blood for 
either 3 or 10 days (Figure 2.3 and 2.4). Good signal-to-noise spectra were obtained from 
these experiments; however, the modifications to the DNA backbone also increased the 
 
Figure 2.3. SERS on a AgFON of (a) nuclease-resistant ricin B chain aptamer (b) 
nuclease-resistant ricin B chain aptamer in whole-human blood for 3 days (c) 
nuclease-resistant ricin B chain aptamer after exposure to ricin B chain in blood. 
Each trace is an average of 7 spectra acquired from 7 randomly selected spots.  
Spectra are artificially offset for clarity. On the right, PCA plot shows grouping of 
the nuclease-resistant aptamer (blue dots), nuclease-resistant aptamer in blood 
(purple dots), and nuclease-resistant aptamer in blood after exposure to ricin B 
chain (green dots).    
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spectral complexity.  Two strategies were employed to evaluate the sensor performance 
despite the spectral complexity.  The first was computational modeling of the DNA SERS 
spectrum expected on a Ag plasmonic surface so that particular Raman bands could be 
attributed directly to the aptamer affinity agent.  The second was principle component 
analysis (PCA) to help differentiate small changes in the spectral patterns in these 
complex environments. 
The computational model of the aptamer Raman spectrum assumes that the 
aptamer is perpendicular to the surface.22,23  In addition, based on the well-known 
distance dependence of SERS enhancement, the first few DNA bases, adjacent to the 
thiol, were given priority when considering contributions to the spectrum.61-64  The bases 
after the first 7 were treated in one of two ways: either (1) the bases were all considered 
to be the same distance from the surface or (2) the bases were all considered to be too far 
away from the surface to contribute to the spectrum.  While the aptamer does contain a 
hairpin loop and bulge at C15-G25 and G10-C29, respectively, these assumptions are not 
influenced based on the distance between both the hairpin and bulge from the Ag 
surface.22 The intensity of the computationally derived aptamer spectrum can be 
expressed from Eq 1 and Eq 2 found in the supporting information, and the results of the 
aptamer spectral modeling can be seen in Figure S3 in the supporting information. The 
experimentally and computationally derived spectra are in good agreement (Figure 2.4) 
with the major contributions in the spectra resulting from adenine and guanine scattering. 
As can be seen, the spectrum of the nuclease-resistant aptamer still exhibits peaks from 
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adenine and guanine, although differing in intensity compared to the natural aptamer 
backbone. Due to the complexity of the spectrum when incubated in blood, PCA was 
utilized to evaluate the effectiveness of our detection method.  In Figure 2.3, the principal 
component analysis shows the nuclease-resistant aptamer spectra clustering together, the 
nuclease-resistant aptamer spectra captured after exposure to blood clustering together, 
and the nuclease-resistant aptamer spectra captured after exposure to both blood and ricin 
B chain clustering together.  More importantly, there is no overlap between different 
spectral classes in the principle component analysis.  In future experiments, this may be 
applied to a training data set to identify the presence of ricin B chain among unknown 
 
Figure 2.4. SERS on a AgFON of (a) nuclease-resistant ricin B chain aptamer in blood 
for 10 days (b) nuclease-resistant ricin B chain aptamer in whole-human blood for 10 
days followed by ricin B chain exposure (c) AgFON in human whole blood for 10 days.  
Spectra are artificially offset for clarity. On the right, PCA plot shows grouping of the 
nuclease-resistant aptamer (blue dots), nuclease-resistant aptamer in blood (orange 
dots), and nuclease-resistant aptamer in blood after exposure to ricin B chain (red dots).    
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protein analytes.  To evaluate specificity of the aptamer-modified AgFON for ricin B 
chain, control experiments with BSA (bovine serum albumin) were conducted; the 
prinicipal components due to the BSA-exposed aptamer-functionalized substrates 
clustered separately from the ricin B chain exposure experiments.  BSA was chosen to 
evaluate specificity because of the relatively high concentration of albumin in blood (3.5-
5.0 g/dL) and its similarity in size to intact ricin.13,65   Figure 4 shows the spectra 
recorded for the aptamer after exposure to blood for 10 days (bottom) and the aptamer 
after exposure to blood and ricin B chain for 10 days (middle).  As can be seen in the 
spectra, the peaks that are normally very prominent for the aptamer after shorter blood 
exposure times are now shoulders of peaks due to blood components.  The aptamer peaks 
are still present in the bottom two traces, however in the top control trace with just blood, 
there are no aptamer bands while the shoulders that appear in the bottom two spectra are 
not present in the control spectrum.  While the typical experimental protocol was to 
measure at 7 different locations on each AgFON, the silver surface partially delaminated 
during these long-term blood exposure experiments, leaving only a few active areas on 
the substrate.  During the ricin B chain exposure, the AgFON further delaminated, 
leaving only 3 locations to be measured.  However, the three different classes of 
experiments cluster separately following PCA analysis, indicating that, of the surfaces 
that remained intact, it was still possible to distinguish between the nuclease-resistant 
aptamer in blood and the nuclease-resistant aptamer exposed to ricin B chain. Future 
work in substrate design will focus on increasing the mechanical robustness of these 
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plasmonic surfaces while maintaining the enhancement factor and the ability to modify 
the structure with desired affinity agents.     
2.3.1 Reversibility   
Ideally, the interaction between the aptamer and target analyte would be 
reversible so that the sensing platform could be reused. Ricin is known to be highly 
resistant to both heat and pH, 66-68 and there are limited publications on the inactivation of 
ricin.67-69 In attempt to achieve reversibility, the interaction between the aptamer and 
RBC, 
association was studied under various conditions, including varied temperature, pH and 
ionic strength. SERS signal responses to all of these conditions were identical. For 
brevity, only the influence of elevated temperature on the sensor performance is 
discussed in detail.  
Prior to direct study of the stability of the association between the protein and the 
aptamer, it was important to first characterize the physical conditions that might induce 
disassociation of the aptamer from the AgFON surface or cause damage to the AgFON 
 
Figure 2.5. SEM images of AgFON before (left) and after (right) 
thermal treatment for 5 minutes at 95 C°. Scale bars indicate 200 nm. 
 
 
 46 
 
itself. Again, benzenethiol was employed as a model molecule to study the stability of the 
thiolate-silver interaction as well as the stability of the AgFONs themselves. While there 
is much precedent work exploring the thiolate-Au dissociation, there are no systematic 
studies of the stability of thiol-silver interactions.67,68,70 
Herdt et al reported degradation of DNA-Au conjugation at 70 °C within hours. 
54,69Therefore, to study the stability of S-Ag interaction at elevated temperature, the 
temperature range considered herein is 70-95 °C, where 95 °C is the temperature 
typically used to fully unfold the aptamer (ricin B chain aptamer is known to maintain its 
conformation in the temperature range of 4-63 °C). 22 As shown in Figure 2.5, the Raman 
bands at 1073, 1024, 1001, and 695 cm-1 shift are attributable to benzenethiol while the 
1349 cm-1 shift peak is due to residual ethanol. As one might predict, higher temperature 
accelerated the dissociation of the S-Ag conjugation. Taking the intensity of peak 1073 
cm-1 shift as an example (other benzenethiol peaks followed the same trend), the peak 
intensity decreased with increasing temperature. After the thermal treatment at 95 °C, a 
significant decrease of the SERS signal was revealed by two-tailed t-test (p value after 30 
s treatment is 0.0006 and after 5 min treatment is 6 ! 10-6). In addition, incubation at 70 
°C for 30 s did not impact the SERS of benzenethiol (p value = 0.93) while the SERS 
signal variance at 70 °C for the 5 minute incubation was significant (p value = 0.01), 
indicating that the longer incubation time enhanced the dissociation of benzenethiol from 
AgFONs. While these signal intensity losses may, in fact, be due to dissociation of the 
thiolate-Ag interaction, there are other potential contributing factors to keep in mind. 
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First, silver is a highly oxidizable metal that can also undergo annealing processes, 
known to be even more vulnerable in nanoscale than bulk form.71 Second, Raman 
scattering efficiency is highly dependent of the molecular orientation of the scatterer on 
the SERS substrate; it is possible that the temperature elevation, even for short time 
periods, causes a reorientation of the benzenethiol, rendering it a less efficient scatterer. 
Thus, we assume that all three factors, dissociation of thiolate-Ag conjugate, damage to 
the AgFON surface, and reorientation of molecular species contribute to the SERS signal 
decline. The post-thermal treatment AgFONs were reincubated in the benzenethiol stock 
solution and then analyzed by SERS again. The results showed that the AgFON treated at 
a lower temperature and for a shorter time period recovered the initial SERS benzenethiol 
signals following reincubation. In contrast, the AgFONs that were treated at the highest 
temperature did not recover the benzenethiol SERS spectra following reincubation.  This 
experiment demonstrates that the SERS signal decay at high temperature includes some 
contribution of permanent damage to the AgFON nanostructure. Figure 2.6 shows the 
SEM images of the AgFONs before and after the thermal treatment at 95 °C. The sharp 
features on the original AgFON anneal, decreasing the roughness of the surface and 
leading to a lower SERS enhancement. The visible black spots on the SEM image in the 
post-thermal treatment AgFON indicate areas devoid of Ag coverage. Based on these 
experiments, it is clear that high temperatures and long temperature excursions times are 
not appropriate condition changes to induce reversibility in this ricin B chain sensing 
system.  
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Thermal treatments were performed on the RBC-exposed aptamer-functionalized 
AgFONs. The SERS signal of aptamer at 731 cm-1 shift decreased 31.6% after thermal 
treatment at 80 C°, significantly (p value = 0.03) more than the benzenethiol signal 
decline under the same conditions (SERS signal of benzenethiol at 1071 cm-1 decreased 
13.5% after thermal treatment at 80 C°), indicating that the conformational change of 
ricin B chain aptamer caused by the thermal treatment contributes to the decline of the 
SERS signal. Even though there is a clear decline in the SERS signal intensity following 
thermal treatment, the 1274 cm-1 shift peak that indicates the presence of ricin B chain 
was still measurable (Figure 2.7). Slight modifications of the detailed thermal treatment 
have been performed, including heating under N2 gas and heating at a lower and 
physiological temperature for an extended time period (37 °C for 24 h). In all these 
variations, the 1274 cm-1 shift peak remains in the SERS spectrum.  
Ionic strength and pH are known to influence the conformation of DNA, thus, 
variation in these conditions present another potential avenue for intentionally 
destabilizing the aptamer/target interaction. SERS spectra of the post-treatment 
benzenethiol-functionalized AgFONs revealed no obvious changes when compared to the 
pre-treatment conditions (Figure S1 in supporting information), indicating that substrate 
and the S-Ag conjugate are stable in a 1 M NaCl solution and within the pH range from 
5-8. Under these conditions, a decrease in the aptamer-RBC conjugate SERS signal 
would likely due to the dissociation of RBC from the aptamer. However, similar to 
thermal treatment, the association of aptamer and RBC was intact during the treatment 
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according to the SERS spectra. In summary, 95 °C, 1 M NaCl and pH 5-8 were not able 
to induce the dissociation of RBC from the capture aptamer without also irreversibly 
damaging the plasmonic substrate. 
 
 
 
Figure 2.6. SERS of aptamer and aptamer-ricin B chain conjugates on 
AgFONs before and after thermal treatments. 
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Figure 2.7. SERS of benzenethiol on AgFONs treated at elevated 
temperature for a) 30 s or b) 5 min. The spectra are vertically off-set for 
clarity, %ex  = 633 nm. Each trace is the average of 10 randomly chosen spots 
on the AgFON *Need to include parallel details to other captions about 
number of averaged spectra, etc* c) shows benzenethiol SERS intensity at 
1071 cm-1 shift decreasing with increasing temperature, the far left spots are 
the intensities before the thermal treatments, the far right spots are the 
intensities after the AgFONs reincubated with benzenethiol stock solution 
(the purple spectra in both (a) and (b). 
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2.4 Conclusions 
The detection of ricin B chain in whole human blood was performed on aptamer-
functionalized AgFONs via SERS.  AgFONs were shown to be stable in whole blood for 
10 days.  A modification to the aptamer DNA backbone was needed to ensure stability of 
the aptamer for more than 1 day in whole human blood.  While many attempts were made 
achieve reversible interaction of the aptamer and ricin B chain, the interaction persisted 
after substrate exposure to low pH, temperature elevation, and high ionic strength; more 
work is required to achieve reversibility, perhaps using a lower affinity aptamer 
sequence.  Principle component analysis of SER spectra reveal ricin B chain detection 
after even 10 days in human whole blood at a concentration that would be fatal.   
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Chapter 3. Microfluidic-SERS Devices for One Shot Limit-of-Detection 
*Adapted from:  
Microfluidic-SERS devices for one-shot limit-of-detection, Campos, A.R., Kim, D., Datt, 
A., Gao, Z., Rycenga, M., Burrows, N., Greeneltch, N.G., Mirkin, C.A., Murphy, C.J., 
Van Duyne, R.P., Haynes, C.L., Analyst, 139, 3227–3234 (2014). 
 
3.1 Introduction 
Microfluidics is an often-used technique for sample manipulation in bioanalytical and 
biomedical sciences because the devices are largely biocompatible, require small (viz., 
nanoliter) sample volumes, create small volumes of biohazard waste, and enable faster 
analyses and higher throughput than many bench-top techniques. These advantages make 
microfluidics especially promising for biological applications and bioanalytical sensor 
developments, particularly when interrogated with optical detection schemes. Among the 
various optical detection methods that can be used in conjunction with microfluidic 
platforms, Raman spectroscopy is particularly interesting for bioanalytical applications 
because it yields an intrinsic vibrational fingerprint for detected analytes, and its 
performance is not compromised by water interference in aqueous samples. Normal 
Raman spectroscopy has inherently small scattering cross-sections, yielding poor analyte 
sensitivities; however, surface-enhanced Raman scattering (SERS) provides opportunities 
to enhance detection sensitivity significantly.1-4 This enhancement is attributable to the 
large molecular dipole moment induced when a Raman-active molecule experiences the 
electromagnetic fields generated at the surface of nanostructured plasmonic noble metals. 
Practically speaking, the SERS limit of detection can reach the single-molecule detection 
realm, but nanomolar and picomolar analyte concentration detection is routinely observed 
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with high quality plasmonic substrates.5-9 Accordingly, SERS has been employed in 
microfluidic platforms to identify chemical moieties in bioanalyte systems including 
cells, viruses, bacteria, organelles, sub-organelles, DNA, proteins, drugs, and cellular 
communication mediators.8-13 
Colloidal noble metal nanoparticles are the most commonly used SERS-active substrates 
within microfluidic devices.1,14-18 In general, the SERS-active nanoparticles are injected 
through a microfluidic channel where they encounter analyte species at a specified 
physical location within the device. The primary challenge with this type of approaches is 
that it is difficult to achieve large and consistent signal enhancement45-49 without 
controlled colloidal nanoparticle aggregation.5,18,50 It has been reported that the best 
SERS signal enhancement for gold nanoparticles can be achieved when nanoparticles are 
in contact, or at least separated by not more than 1-2 nm;5,18,50 however, the challenge of 
controlling nanoparticle aggregation presents persistent experimental roadblocks related 
to stability, sensitivity, and reproducibility of the obtained signal both in and out of 
microfluidic devices. Previous work also reports unexpected loss of nanoparticles or 
defects in their aggregation/arrangement due to nanoparticle interactions with channel 
surfaces or the flow profile.19 To avoid these difficulties, there have been several reported 
systems where a SERS-active substrate is incorporated into a microfluidic device.20-21 In 
these reports, SERS-active substrates were largely fabricated either on glass or silicon 
using high-end lithography techniques, aligned, and bound to a layer containing the 
microfluidic channel geometries. These finely-tuned SERS-active substrates, such as 
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nanoholes or nanogaps,22-27 have very high signal enhancements compared to simple 
colloidal nanoparticles; however, fabrication can be prohibitively expensive and requires 
access to specialized instrumentation for time- and labor-intensive fabrication protocols.  
Herein, we present two types of proof-of-concept microfluidic-SERS sensing platforms 
with potential to address the aforementioned challenges: a microfluidic gold film-over-
nanospheres (AuFON) platform and a flexible SERS sensor platform with nanoparticles 
incorporated directly into the microfluidic polymer layer. Gold was chosen over silver as 
the plasmonic material, despite its lower signal enhancement compared to silver, because 
of its stability against dissolution and oxidation, lower toxicity, and ease of surface 
functionalization for future bioanalytical applications.10-11 
The microfluidic AuFON platform, as the name implies, employs a AuFON as the 
plasmonic component. Multiple groups have previously demonstrated, using silver film-
over-nanospheres (AgFON), that noble metal FON substrates can provide strong, 
reproducible SERS enhancement factors.2,22 Similar capabilities have been reported for 
AuFONs as well.23-29 The most appealing aspect of FONs as SERS substrates is that, 
despite relatively simple and inexpensive fabrication techniques, they exhibit 
extraordinary signal enhancements (106 ~ 108) with uniform and reproducible analyte 
response over square centimeters of substrate areas. As such, the noble metal FONs have 
become the gold standard for SERS substrates. In addition to the aforementioned 
advantages of AuFONs over AgFONs, gold also provides better compatibility than silver 
with the microfabrication techniques used to combine SERS-active substrates with 
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polydimethylsiloxane (PDMS)-based microfluidic platforms.  
For the flexible SERS sensor platform, gold nanorods (AuNRs)37 and gold nanocubes 
(AuNCs)38-39 are used as nanoparticle SERS substrates. These nanoparticles are directly 
dispersed into the PDMS device before curing and enable SERS detection of analytes 
flowing through the device. The relatively simple fabrication of this device adapts to any 
desired channel geometry, retains the optical transparency and flexibility of the device, 
and employs a relatively small number of nanoparticles. To our knowledge, there are 
only a few reported research efforts where nanoparticles were embedded directly into a 
microfluidic device.20,31 In those studies, gold nanocomposites were created by vapor 
deposition or in situ synthesis onto microfluidic channels or by stamping nanocomposites 
onto the side of a microfluidic device. Despite the potential benefits of these methods, the 
in situ synthesis approach and vapor deposition frequently consume an unnecessary 
amount of gold and complicate further device fabrication steps. In addition, the potential 
of those approaches to achieve the optimally enhancing nanoparticle aggregates is 
dubious.  
Employing PDMS-based microfluidics herein enables the realization of a portable, 
durable SERS sensing platform with added analytical strengths. In the proof-of-concept 
microfluidic-SERS sensor platforms presented herein, microfluidic channels are designed 
to enable easy limit-of-detection (LOD) or limit-of-quantification (LOQ) studies. The 
fundamental principle of the device is based on previously reported microfluidic devices, 
capable of creating chemical gradients,32 with a slight modification to achieve 
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simultaneous detection of different concentrations of an analyte. Another advantage of 
the PDMS-based SERS sensor is that PDMS provides strong Raman-active bands in a 
490-700 cm-1 shift region as an internal standard. As our results show, the presented 
microfluidic-SERS platforms are capable of quantitative, single experiment LOD/LOQ 
assessment, and demonstrate their potential for multiplexed high-throughput analysis. 
Further development of these proof-of-concept platforms will facilitate the development 
of several diagnostic devices for early disease detection and continuous monitoring of 
patients. 
 
3.2 Methods and Experimental Setup 
 3.2.1 AuFON fabrication After silicon immersion in a base bath with 10:1:1 
water:ammonium hydroxide (30%):hydrogen peroxide (30%) for an hour, 13 µL of  600-
nm-diameter silica nanospheres (Bangs Laboratories, Fishers, IN) were drop cast onto the 
clean silicon wafer. The silica nanospheres were distributed on the silicon wafer until 
there were no visible mixing lines, and then the wafer was allowed to air dry.  After 
nanosphere self-assembly and drying, 200 nm of Au (99.999 % Au Kurt J Lesker, 
Clairton, PA) was deposited onto the nanosphere template under vacuum, as measured by 
a quartz crystal microbalance (Denton Vacuum, Moorestown, NJ).  The localized surface 
plasmon resonance (LSPR) of the substrate was measured to be %max= 790 nm using a 
fiber optic probe (Ocean Optics, Dunedin, Florida) with a flat gold film as the reflective 
standard, and the AuFONs were stored in a closed petri dish until use. 
 
 
 57 
 
 
 3.2.2 Au concave nanocube (AuNC) synthesis Gold concave nanocubes 
(AuNCs, 53 ± 10 nm in edge length (n=30), 4 nM as synthesized) were fabricated in a 
synthesis adapted from Rycenga et al.38-39 In brief, Au seeds were prepared by quickly 
injecting 0.60 mL of ice-cold, freshly prepared NaBH4 (10 mM) into a rapidly stirring 
solution containing 0.25 mL of HAuCl4 (10 mM) and 10.0 mL of 
cetyltrimethylammonium chloride (CTAC, 100 mM). The seed solution was stirred for 1 
minute and then left undisturbed for 2 hours. A growth solution was prepared by 
consecutively adding 0.50 mL of HAuCl4 (10 mM), 100 (L of AgNO3 (10 mM), 0.20 mL 
of HCl (1.0 M), then 0.10 mL of ascorbic acid (100 mM) into 10.0 mL of 0.1 M CTAC. 
The seed particles were serially diluted in 100 mM CTAC to generate a solution 1/1000 
the concentration of the original seed solution. Particle growth was initiated by adding 
0.1 mL of the diluted seeds to the growth solution. The reaction was swirled immediately 
after the addition of the seeds and then left undisturbed on the bench top overnight.  The 
in-solution LSPR %max was 618 nm. 
 
 3.2.3 Au nanorod (AuNR) synthesis Gold nanorods (AuNRs, 48 ± 11 x 13 ± 2 
nm (n=30), 5 nM after washing) were prepared on a two-liter scale in a millifluidic flow 
reactor following previously published procedures37 based on a seeded growth 
approach.40-42 Briefly summarized, two solutions were prepared, labeled “growth” and 
“seed”. For the growth solution, 98.55 mL of HAuCl4 (0.01M), 12.0 - 18.3 mL of 
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AgNO3 (0.01M), and 10.84 mL of ascorbic acid (0.1 M) were added to 0.1 M CTAB 
(cetyltrimethylammonium bromide) with a final volume of 1 L. For the seed solution, 
2.365 mL of gold nanoparticle seeds prepared following previously established methods4 
was added to CTAB (0.1M) with a final volume of 1 L. Then, these solutions were 
combined via peristaltic pump (Cole-Palmer Masterflex L/S) in a millifluidic reactor 
(Tygon polyvinyl tubing, i.d. = 2.79 mm) with: 1) polyethylene Y-mixer and joints, 2) a 
flow rate of approximately 8.0 mL/min, and 3) a residence time of 20 minutes. Gold 
nanorod suspensions were eluted from the reactor into an aqua regia-cleaned two-liter 
Erlenmeyer flask with magnetic  
 
Figure 3.1. Device design (left) and photographs of microfluidic-AuFON (middle) and 
flexible SERS sensor (right). 
 
stirring and held for 2–3 hours prior to purification, concentration, and characterization. 
Gold nanorods were concentrated and purified by washing with centrifugation. The 2 
liters of suspension was divided into 50-mL centrifuge tubes and centrifuged at 11,000!g 
for 15 minutes. The supernatant was syphoned off, and the pellets were redispersed in 1 
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mL of nanopure water, each, and combined into eight centrifuge tubes filled to 40 mL 
with nanopure water. These were then centrifuged at 5,000!g for 25 minutes, syphoned, 
and dispersed in nanopure water.   This process was repeated twice more with CTAB 
(800 (M) for dispersing the pellet.  The suspension was then centrifuged one last time at 
5,000!g for 25 minutes with the pellets combined into one centrifuge tube and dispersed 
in CTAB (800 (M). The resulting suspension was then characterized using UV-Vis-NIR 
spectroscopy, DLS, PALS, and a bromide ion-selective electrode. The in-solution LSPR 
%max values were 526 nm and 760 nm, and the resulting nanorod concentration was 5 
nM. 
 3.2.4 Nanoparticle characterization These colloidal nanoparticles were used in 
the synthesis of flexible SERS sensor platforms—detailed below—and likely retain some 
CTAB/CTAC  moieties on their surface.25,26 Characterization of these nanoparticles was 
performed by transmission electron microscopy (TEM, FEI Tecnai T12 electron 
microscope operating at 120 kV) and UV-vis extinction (Ocean Optics, Dunedin, 
Florida).  
 
 3.2.5 Microfluidic-AuFON device fabrication Standard photolithography 
procedures described in a previous paper were followed for device fabrication.33 Briefly, 
the device design (Figure 1), printed onto a transparent film (CAD/Art Services Inc., 
Bandon, OR), was transferred to a blank chrome mask plate (Nanofilms, Westlake 
Village, CA). Then, using the mask, the design was transferred to a SU-8 photoresist 
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layer (Microchem, Newton, MA) on a silicon wafer. Then, de-gassed 10:1 weight ratio of 
Sylgard 184 resin and curing agent mixture (Ellsworth Adhesives, Germantown, WI) was 
cast onto the master and cured at 65 ! overnight to complete the PDMS channel layer. 
Channel dimensions were 100 µm wide and 100 µm high. For practical purposes, the 
terminal channels where measurements were performed had 1000 µm width. Bonding of 
the PDMS layer to AuFON was done via oxygen plasma treatment at 100 W for 10 
seconds after inlet and outlets were punched. All fabrication steps were performed in the 
Minnesota Nano Center (MNC) at the University of Minnesota.  
 
 3.2.6 Flexible microfluidic-SERS sensor device fabrication Flexible SERS 
sensors were fabricated using the same SU-8 mold used for the microfluidic-AuFON 
devices. Nanoparticle solutions (1 mL of 5 nM AuNRs or 4 nM AuNCs in water) were 
centrifuged at 10,000!g for 10 minutes, and the supernatants were removed using a 
micropipette. Then, the nanoparticles were re-suspended into 100 µL of the curing agent 
component of Sylgard 184, mixed with 900 µL Sylgard 184 resin, de-gassed, and finally 
poured onto the terminal channel array area of the SU-8 mold. After 30 minutes of curing 
on a 65 ! hot plate, 10:1 resin:curing agent mixture of Sylgard 184 was poured onto the 
mold, covering the entire device design, and cured overnight. Then, the device layer was 
peeled, cut, and punched for inlets and outlets. At this stage in device fabrication, SERS 
measurement on the microfluidic platform was possible but often not successful, likely 
because a large majority of the nanoparticles were completely incased in PDMS (i.e. not 
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exposed to the in-channel stream of analyte). To enhance nanoparticle/analyte interaction, 
the PDMS layer was dry etched via reactive ion etching (75% CF4 and 25% O2, 100W, 
one hour) and then this layer was bound to another clean and flat PDMS layer via oxygen 
plasma treatment. 
 
 3.2.7 Analyte Solution preparation 10 mM trans-1,2-bis(4-pyridyl)ethylene 
(BPE, Sigma Aldrich) was prepared in ethanol, followed by dilution to 10 nM with 
MilliQ water (Millipore, Billerica, MA). 50 µM rhodamine 6G (R6G, Sigma-Aldrich, St. 
Louis, MO) stock solution was also prepared in ethanol, and the final 1 µM R6G solution 
was prepared by diluting the stock with MilliQ water. 
 
3.2.8 Fluorescence microscopy An inverted microscope with a 20x objective (Nikon, 
Melville, NY) and a CCD camera (QuantEM, Photometrics, Tucson, AZ) was used to 
collect on-chip fluorescence images in three replicates. Metamorph Ver. 7.7.5 was used 
as the imaging software. Images of each channel were acquired with 10 ms exposure 
times. Once collected, the maximum fluorescence intensity, in arbitrary unit (AUmax), in 
the region was recorded from each channel. 
 
3.2.9 SERS measurements The prepared microfluidic-AuFON device substrate was 
attached to the xyz stage (Thor Labs, Newton, NJ), and SERS spectra were measured 
with a SnRI ORS system (%ex=785 nm, Snowy Range Instruments, Laramie, WY). The 
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LSPR lmax values the SERS substrates were 790 nm for the AuFON, 760 nm for the 
embedded AuNRs, and 618 nm for the embedded AuNCs; thus, the SnRI ORS system 
excitation wavelength is most appropriate for the AuFON and AuNR substrates. An xyz 
micromanipulator stage was used to achieve fine control over the measurement spot 
locations and focus throughout the experiment. Measurements were made across all five 
channels at five different positions within each channel.  An averaged spectrum was 
collected (three replicates for 1 second each) at an incident laser power of 3 mW for each 
position. SERS  
 
Figure 3.2. Microfluidic platform design and COMSOL modeling for the mixing process 
(diffusion coefficient of 1.0 x 10-5 cm2/s and flow rate of 10 µL/min). 
 
measurements were conducted after 10 minutes flow through the device to ensure that the 
gold surface was equilibrated to the solution-phase analyte concentration so that the 
measurement was not biased with time.  
To be noted, a sharp Raman peak was frequently obtained at ~520 cm-1 shift in the 
flexible SERS sensors. In the literature, several studies have observed this peak during 
SERS measurements in a PDMS device; the most convincing identity of this peak is 
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mono- or poly-crystalline silicon.35,36 For SERS measurements in the flexible SERS 
sensor, a silicon wafer was always present underneath the flexible SERS devices during 
measurements to better visualize the channels, which may have led to the sharp Raman 
peak. Another possibility is that the reactive ion etching chamber is frequently used for 
silicon etching, and a silicon wafer was present in the chamber during etching of the 
flexible SERS PDMS layer; as such, the Au nanoparticles may have been exposed to 
silicon during the etching process. This 520 cm-1 shift band was not considered when 
assessing the performance of these devices. 
 
3.3 Results and Discussion 
 3.3.1 Device operation/simulation The microfluidic device used herein was 
designed to establish a concentration gradient of injected solutions so that a range of 
discrete concentrations are presented to each detection element.32 Once solution 1 and 2 
are injected through inlets 1 and 2, respectively, the solutions repeatedly mix and split 
while passing through serpentine channels (denoted as mixing channels, Figure 3.2). The 
original millifluidic design combines all branches at the end so that a linear concentration 
gradient of the solution is established in one wide channel downstream of the mixing 
channels,20 but herein, all outcome branches are separated so that the analyte coming out 
of each channel can be individually monitored. To achieve the desired results, complete 
mixing is required within each mixing channel. Computational fluid dynamics (CFD) 
calculations assuming a 3-dimensional single laminar flow model were performed using 
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COMSOL Multiphysics 4.3 to assess the mixing process for the given channel geometry 
(Figure 3.2). Channel dimensions were modeled as fabricated except that the channel 
height was set as 50 µm with symmetry to shorten computing time. As such, in this 
simulation, incompressible flow and the no slip boundary condition were used with user-
defined diffusion coefficients, ranging from 0.5 x 10-5 cm2/s to 1.0 x 10-5 cm2/s, and flow 
rates  
 
Figure 3.3. (a) Complete microfluidic device without SERS substrate - water into the left 
inlet and 1 µM R6G solution into the right inlet to demonstrate the device design and 
functionality.  Red boxes on the device design denote the locations of the fluorescence 
images from the working device. (b) Representative fluorescence response analysis. 
 
of 5, 10, 20, and 30 µL/minute. Figure 3.2 shows the microfluidic device design with a 
representative simulation data plot. The simulation results confirm that, in all given 
conditions, each mixing channel achieves complete mixing (i.e., the device operates as 
desired). In the experiments described below, a flow rate 10 µL/minute was used. 
 
 3.3.2 Fluorescence imaging Before performing SERS measurements, device 
performance was experimentally evaluated by fluorescence imaging. Figure 3.3a shows 
the actual device bound to a clean glass substrate and fluorescence images from each 
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location marked using red boxes. By visual inspection, the achieved fluorescence images 
showed the expected behavior, and thus, the obtained data were further analyzed 
quantitatively. Figure 3.3b summarizes fluorescence intensity data (maximum 
fluorescence intensity in arbitrary unit, AUmax) for R6G introduced into 3 representative 
devices. In total, seven devices were tested for linearity of fluorescence response from the 
channel arrays, and the average R2 value was 0.94 ± 0.02 (mean ± standard error of 
mean). This linear response was further evaluated by obtaining measurements from 3 
vertical locations in each of the five terminal channels of a device (Figure S1). For this 
assessment, fluorescence intensity from the array of five channels was obtained from 3 
fixed y-axis positions of the stage, and all collected data demonstrated linear response 
from the array of channels with R2 values better than 0.90. 
 
 3.3.3 SERS assessment of the microfluidic-AuFON device Having achieved 
the desired performance of the microfluidic portion of our sensing platform, we next 
evaluated SERS performance of our microfluidic-AuFON platform. As PDMS does not 
bind well to gold surfaces, the AuFON was intentionally removed at preferred device 
binding locations to expose the silicon surface, which does bind to PDMS. Then, oxygen 
plasma treatment was used to induce permanent bonding between the PDMS device and 
AuFON substrate.  Once assembled as shown in Figure 3.1, a BPE solution was 
introduced into the device following the same procedure used for fluorescence imaging: 
media without BPE into one inlet and BPE solution into the other inlet using a 10 
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µL/minute flow rate. We started with a high concentration of BPE (10 mM). BPE is 
known to adsorb onto noble-metal surfaces,43-45 so the channels were rinsed with water 
before SERS measurements. The LSPR %max of the in-device AuFON was 790 nm, a 
good plasmonic match for the SERS  
 
Figure 3.4. (a) Device design, (b) representative SERS spectra (BPE-characteristic bands 
marked with *) from the microfluidic-AuFON, and (c) SERS response analysis from 3 
separate devices/substrates. Solvent vs. 10 nM BPE solution (BPE peak used for analysis: 
1640 cm-1) was used as the analyte system. 
 
excitation wavelength of 785 nm. The SERS spectrum of BPE has characteristic bands at 
1021, 1210, 1610, and 1640 cm-1 shift,22 and all of these bands were observed in the 
measurement terminals (data not shown). All attempts confirmed that the characteristic 
BPE bands were a result of SERS, rather than normal Raman from the solution, because 
the SERS bands were still present after rinsing with water in the channels or after the 
device was allowed to dry (data not shown).  
As such, a much lower concentration of BPE (10 nM) was used to further evaluate the 
utility of the microfluidic-AuFON platform. From the left to the right in Figure 3.4a, the 
expected concentrations from each outlet channel are 0, 1.25, 5, 8.75, and 10 nM. All 
BPE-characteristic SERS bands are obtained from individual channels with varying 
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intensities (Figure 3.4b) and a complete calibration curve with the assessment of 
LOD/LOQ was successfully obtained (Figure 3.4c). It should be noted that we observed 
device-to-device variations, based on differences in AuFON quality. However, 
irrespective of the overall quality of the AuFON, the device showed linear response to 
linear concentration gradients of BPE. Even though measuring BPE concentrations lower 
than 1 nM was not successful every time, the difference between the 0 nM channel and 
the 1 nM channel was always clear, and LOD evaluation by extrapolation (Figure 3.4c) 
yields different LOD/LOQs in the nM range (see Table 1 for a complete listing of 
LOD/LOQ values for all devices) for the microfluidic-AuFON devices. On a few 
occasions, the first channel, which should present no analyte, showed a low intensity BPE 
signal. This is due to an imperfection at the beginning of the device operation where BPE 
solution reached the detection terminal as bubbles were removed from the device, which 
can be easily corrected in future work. 
 
Fluorescence Microfluidic-AuFON 
Flexible SERS sensor 
AuNR AuNC 
Device 1 0.30/0.90 5.76/17.46 0.69/2.09 0.86/2.61 
Device 2 0.30/0.88 3.73/11.30 0.55/1.65 0.53/1.62 
Device 3 0.50/1.50 2.83/8.58 0.44/1.33 0.42/1.27 
Table 1. Values are in LOD/LOQ format. (Fluorescence: uM, AuFON: nM, Flexible: 
mM).  
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Interestingly, different BPE Raman bands result in differing slopes in linear regression 
analysis (Figure 3.5). This result is interesting because the peak heights are the product of 
the substrate enhancement factor (EF), Raman scattering cross-section, and concentration 
of the analyte. Assuming a constant EF with a known concentration of analyte in the 
channel, the slopes from all bands would be similar if the vibrational cross-sections were 
similar. Another potential explanation for this variation in slope could be due to the data 
processing and analysis routine where the presented data is obtained after baseline 
subtraction using an in-house algorithm. The algorithm is imperfect at choosing good 
baseline values, especially when the spectrum is crowded, and this could contribute to the 
variation in our linear regression analysis. Further analysis will be needed to delineate  
 
Figure 3.5. SERS response analysis a microfluidic-AuFON platform with 10 mM BPE  
whether this is an artifact of analysis or a true reflection of scattering cross-section 
differences among vibrational modes. 
 
 3.3.4 SERS assessment of the flexible microfluidic-SERS sensor device 
 The performance of the flexible SERS device was assessed using the same 
experimental system detailed above. The device performance was assessed in a step-by-
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step fashion to characterize the performance of the Au nanoparticles embedded within the 
PDMS layer. As a preliminary experiment, a prototype straight channel microfluidic 
device was fabricated (Figure 3.6) with channel dimensions of 2000 µm (width) x 50 µm 
(height) x 25000 µm (length) with incorporated citrate-capped gold nanospheres 
(AuNSs). Without dry etching, a small SERS signal was recorded, indicating that at least 
some of the AuNSs were extruding out of PDMS surface to make contact with the in-
channel analyte. However, the success rate of obtaining high quality SERS spectra was 
significantly lower than that achieved with devices that underwent reactive ion etching 
(Figure S3). Scanning electron microscopy (SEM) assessment of nanoparticle-embedded 
PDMS, after reactive ion etching, clearly demonstrates nanoparticles protruding from the 
PDMS surface. SERS spectra of 1 mM BPE and 1 mM benzenethiol, both well-known 
SERS probes, were successfully obtained using the preliminary flexible AuNS SERS 
platform (Figure 3.6c & 3.6d). All characteristic SERS bands for analytes were observed 
from both BPE and benzenethiol, and the enhancement factor was estimated to be 
between 5.9 x 104 and 4.1 x 107 (see Supplemental information for assumptions and 
calculation).5 This enhancement factor range includes values higher than that achieved 
with the nanoparticles in solution, likely because embedded nanoparticles are no longer 
stabilized by citrate ligands and may occur in small aggregates. 
With these preliminary data, we proceeded with well-characterized, high enhancement 
factor-producing AuNCs and AuNRs, both shown in Figure 3.7. All attempts to obtain 
LSPR measurements from the completed device were only marginally successful (Figure 
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S4). This is likely due to the small number density of nanoparticles in these experiments, 
but we could observe a slight LSPR lmax peak shift from the nanoparticles in a completed 
device when compared to the colloidal nanoparticles before incorporation into PDMS. 
The shift is probably due to formation of small nanoparticle aggregates within the PDMS 
media and the increased matrix refractive index by embedding at  
 
Figure 3.6. (a) Photograph of the prototype device. (b) SEM image showing 
nanoparticles extruding out of the PDMS surface. SERS spectra of (c) 1 mM BPE (*: 
BPE peaks) and (d) 1 mM benzenethiol (BT, *: BT peaks) obtained from the prototype 
device (%ex=785 nm, 10 second exposure, 3 mW power, and an average of 3 replicates on 
the Snowy Range Instrument). 
 
least a portion of the nanoparticle in PDMS. Using the same microfluidic platform 
described for the microfluidic-AuFON sensor, AuNRs or AuNCs were directly embedded 
into the terminal channel array portion of the PDMS. 1 mM BPE was used as the analyte 
for this assessment; and as such, the expected concentrations for the five terminals were 
0, 0.125, 0.5, 0.875, and 1 mM BPE. A linearity assessment was performed, comparing 
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the intensity of BPE’s 1640 cm-1 shift band to PDMS’s 490 cm-1 shift band (acting as an 
internal standard). While the LOD was higher than the microfluidic-AuFON platform, the 
flexible SERS sensor with both AuNRs and AuNCs also showed the expected linear 
response to BPE analyte (Figure 3.8). Using a PDMS peak as an internal standard yielded 
a moderate improvement in linearity for the AuNR devices (0.93 ± 0.01, mean ± standard 
error of the mean, compared to 0.90 ± 0.03). The R2 value for AuNC devices was 
improved significantly (0.89 ± 0.03, mean ± standard error of the mean, compared to 0.69 
± 0.05) with this internal standard (Figure S5). Spatial variation in SERS responses 
within each terminal channel was also evaluated at 3 discrete, randomly chosen locations. 
SERS BPE band energies were similar; however, band intensities were somewhat 
variable. This is likely due to random NC dispersion in the PDMS or formation of 
localized electromagnetic hot spots. Together, these results demonstrate the utility of the 
embedded AuNR- and AuNC-based microfluidic-SERS sensors. 
There are many opportunities for further optimization of these flexible devices during the 
fabrication process. For example, the exact amount of gold nanoparticles added to and 
protruding from the PDMS layer has not been optimized. It is already clear, as observed 
under dark-field microscopy (data not shown), that a thinner nanoparticle-containing 
PDMS layer will lead to more uniform presentation of nanoparticles on the surface of 
PDMS while also requiring a smaller number of nanoparticles. This will present an 
opportunity for more reproducible, and potentially  
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Figure 3.7. Nanoparticle characterization. LSPR measurement (a) and TEM images (b) 
of AuNRs and LSPR measurement (c) and TEM images (d) of  AuNCs. *The extinction 
feature at ~680 nm is an instrumental artifact. 
 
more sensitive, SERS measurements. Furthermore, many groups are working to optimize 
SERS enhancement factors by controlling gaps between nanoparticles (e.g., controlled 
fabrication of nanoparticle dimers or trimers).5,18,50 In the flexible SERS sensor platform, 
nanoparticles are embedded and fixed with, presumably, only a portion of the 
nanoparticle protruding into the microfluidic channel. This may allow, for example, 
nanoparticle dimer formation with a reduced degree of freedom and enable 
extraordinarily sensitive SERS sensing. 
 
3.4 Conclusions 
Herein, we explored the use of two microfluidic SERS sensor platforms, a microfluidic-
AuFON and a flexible microfluidic-SERS sensor, for on-line high enhancement factor, 
low volume SERS measurements. The microfluidics portion of the sensor platforms 
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provides desired control over the sample fluids, as simulated theoretically and verified 
experimentally, and varied concentrations of analyte for simultaneous assessment of 
LOD/LOQ by SERS measurements. While the dimension of the entire devices presented 
herein is relatively large (2.5 cm x 7.0 cm), because the aim here was to match the size of 
a standard microscope slide, the overall size can be easily adjusted as required by 
application or substrate dimensions. The material used for SERS detection is gold, a 
noble metal presenting minimum reactivity and toxicity to biological systems. 
Furthermore, the ease of surface functionalization of gold makes microfluidics-SERS 
approaches well suited for applications 
 
 
Figure 3.8. (a) Representative SERS spectra and (b) SERS response analysis from the 
flexible SERS sensor with embedded AuNRs, and (c) representative SERS spectra and 
(d) SERS response analysis from the flexible SERS sensor with embedded AuNCs. 
Solvent vs. 1 mM BPE solution was used as the analyte system. 
 
where it is necessary to introduce biological functionalities (e.g., antibodies, aptamers, 
enzymes, nucleic acids, proteins, or small molecules). 
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Once incorporated with such surface functionalities, simultaneous detection of multiple 
analytes with high throughput should be easily achieved. Live cell imaging is another 
potential application for the presented sensor platforms as the flexible SERS sensor 
approach may provide an opportunity to allow membrane-specific SERS imaging. 
Further developments of our proof-of-concept microfluidic SERS sensor platforms will 
provide unique advantages to researchers in the bioanalytical sciences and bring 
significant impact in biomedical applications by providing opportunities for wearable 
sensors or on-site (portable) point-of-care devices. 
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Chapter 4. Gold Aggregates Encapsulated in Mesoporous Silica: An 
Ultrastable and Reversible pH Nanosensor  
 
4.1 Introduction 
Over the past decade, surface-enhanced Raman spectroscopy (SERS) has emerged as a 
powerful tool for biosensing applications based on the capacity to perform analyses in 
biological matrices with minimal interference from water.1-5 The pH in biological 
systems is crucial to the stability of organisms.  In particular, the pH of blood is carefully 
controlled to within 0.1 pH unit, and is critical for the health of vertebrates.  The ability to 
monitor the pH of an invertebrate noninvasively through spectroscopic means would 
offer insight into the overall health of the organism. One critical sensing need is in 
intracellular pH level sensing for extended periods of time, and colloidal nanoparticle-
based SERS may be one way to address this need.  The current state-of-the-art 
continuous, long-term, intravascular pH sensor is a product named Paratrend 7+ and 
Neotrend.  These devices can operate as optical or electrochemical detection, but suffer 
from several limitations including unreliable measurements with changes in blood flow, 
lack of robustness, bulky, and long warm-up times.  Literature precedent shows the use of 
various SERS based systems based on gold and silver platforms for pH sensing 
applications; 6,7 however, these pH nanosensors have various limitations, such as toxicity 
in the case of silver, interference by proteins with the SERS tags in an intracellular 
environment, and uncontrollable aggregation of the nanoparticles.8,9 These limitations 
either lead to an inherent lack of compatibility with biological systems or a sensor that 
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cannot perform reproducibly. Recently, researchers have shown that encapsulating noble 
metal colloidal nanoparticles in a polymer or silica matrix can help combat the 
aggregation and stability concerns.10, 11 A complication in using a coated SERS 
nanoparticle is that SERS signal transduction is a highly distance-dependent 
phenomenon, 12,13 where only analytes within about 5 nm of the noble-metal 
nanostructured surface experience the electromagnetic fields that lead to signal 
enhancement.13 Thus, mesoporous silica coatings may facilitate protection of the SERS 
nanoparticle while also allowing analyte species to approach the plasmonic substrate. 
 
Figure 4.1. Overall synthesis and characterization of AuNPs@MBA@MS 
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Mesoporous silica shells offer the additional advantages of having a large surface area, 
tailorable chemical modification of the surface, and biocompatibility.14  
Of the various pH nanosensors that have been fabricated, there is very little precedence 
for stability and reversible sensing in physiological conditions such as human whole 
blood. Another critical component of the pH nanosensor is the ability to recover the 
nanomaterial from human whole blood after the sensing experiments and then perform 
further measurements on the 
recovered nanoparticles.  
Recovery of the gold 
nanoparticles has not been 
shown in previous studies.  
The work herein demonstrates 
a pH nanosensing platform 
where a mesoporous silica-
encapsulated gold 
nanoparticle aggregate facilitates SERS-based pH sensing in whole human blood.  
4.2 Experimental 
4.2.1 Materials Required. All chemicals were used as received. N-
Cetyltrimethylammonium bromide (CTAB), tetraethyl orthosilicate (TEOS) were 
purchased from Sigma Aldrich. 2-[Methoxy(polyethyleneoxy)propyl] trimethoxysilane, 
(PEG-silane, MW 596-725 g/mol, 9-12 EO) was obtained from Gelest. Ammonium 
 
Figure 4.2. Representative TEM images of 
AuNPs@MBA@MS. Scale bars indicate 1 µm (left) 
and 200 nm (right).  
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nitrate (NH4NO3) and ammonium hydroxide (NH4OH, 28-30 wt% as NH3) were 
obtained from Mallinckrodt. Absolute anhydrous ethanol 99.5% was purchased from 
Pharmco-Aaper. The de-ionized (D.I.) water was generated using a Millipore Milli-Q 
system.  
4.2.2 Characterization. Transmission electron microscopy (TEM) micrographs were 
taken on a JEOL 1200 EXII with a 100 kV voltage. Powder X-ray diffraction (XRD) 
patterns were measured on a Siemens Bruker-AXS D-5005 X-ray diffractometer using 
filtered Cu K) radiation (%= 1.5406 Å) at 45 kV and 20 mA. UV-vis measurements were 
performed on an Ocean Optics (Dunedin, Florida) spectrometer.  
 
4.2.3 Preparation of mesoporous silica encapsulated gold aggregates functionalized 
with 4-MBA 
4.2.3.1  Stanford Research Institute Nanoparticles: Nanoparticles acquired from 
SRI were comprised of 90 nm citrate capped Au spheres that were coated with 4-MBA, 
aggregated with sodium chloride, and coated with a proprietary polymer to prevent 
irreversible aggregation. The details of the synthesis and coating procedure remain a 
trade secret of SRI.   
 
4.2.3.2 Mesoporous silica coating of gold aggregates: In a typical synthesis, 12 
mg of CTAB and 2.88 mL Au aggregates (2 mg/mL) were dissolved in 21.12 mL of D.I. 
water under vigorous stirring at 50 °C. After 30 minutes of stirring, 424 (L of NH4OH 
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was added and the contents were stirred for another 15 minutes. 220 (L of 0.88 M TEOS 
was then added to the system and the contents were stirred for one hour. After one hour, 
40 (L of PEG-silane was added to the as-synthesized colloidal solution. The mixture was 
stirred again at 50 °C for another 30 minutes and then the contents were transferred into a 
sealed vessel and hydrothermally treated at 90 °C for 24 hours. The as-synthesized 
solution was purified using ethanolic solution of ammonium nitrate (6 g/L). The 
surfactant-extracted nanoparticles were then washed twice with 99.5% anhydrous 
ethanol. The particles were re-dispersed in D.I. water for pH sensing measurements. 
 4.2.3.3 SERS measurements on bare gold aggregates and mesoporous silica 
coated gold aggregates:  
In a typical experiment, 1 ml of the nanoparticle solution is placed in a 1 dram glass vial.  
SERS measurements were performed using a SnowyRange instrument (Snowy Range 
Instruments, Laramie, WY) %=785 nm, acquisition time 10 seconds with a laser power 3 
mW.   
4.2.3.4  Whole blood stability studies: To 0.5 ml of AuNPs was added 400 ul of 
human whole blood. The vial was sealed with parafilm and placed on an orbital shaker at 
room temperature to prevent coagulation of the blood.   
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4.3 Supplementary Figures 
Figure 4.3. UV-Vis data before 
and after coating 
Figure 4.4. Digital images 
showing the reversibility of the 
nanosensor using SDS treatment 
4.4 Results 
These nanoparticles were coated 
with a 6-8 nm mesoporous silica 
shell that was hydrothermally 
treated to increase the stability of the particles.14 To confirm that the particles were fully 
covered in mesoporous silica, TEM analysis was performed on the particles (Figure 4.2). 
To further verify that the particles are coated, UVvis measurements were performed and 
show a 5-10 nm wavelength shift after the coating.15   
As detailed in Figure 4.3, the MBA is pH sensitive as the carboxylic acid is deprotonated 
and converted to the carboxylate ion resulting in the 1400 cm-1 peak. This process is 
reversible and can be cycled many times. The usable range of this sensor is from pH 3 to 
pH 10. In our experiments, the best sensitivity that we achieved was about 0.5 pH units.  
The purpose of coating the AuNPs with mesoporous silica is to increase stability.14 To 
this end we have incubated the MS coated particles in human whole blood over the 
course of 100 days (Figure 4.5).  After the 100-day incubation, the functionality of the pH 
 
Figure 4.3. Extinction spectra of SRI 
nanoparticles before (AuSRI) and after 
mesoporous silica coating (AuSRI@MS) 
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sensor was tested via a simplified 
acid-base titration. While the 
ammonium hydroxide and 
hydrochloric acid caused 
foaming of the blood the sensor 
still showed the characteristic 
1400 cm-1 carboxylate peak upon 
base addition.  In addition, the 
pH sensor was still reversible with the addition of acid. The capability of the sensor 
shows that even though the particles were in human whole blood they still functioned 
reasonably well. Adsorption of proteins to nanoparticles in complex matrices has been 
well studied.16 While protein adsorption to nanosenors generally causes aggregation and 
sensor failure, the mesoporous coating ensures that the noble-metal surface and 
functionalization remains in tact despite protein adsorption.16    
Recovery of the nanoparticles after exposure to blood shows the stability of the particles.  
The particles were recovered using two methods: bleach treatment and sodium dodecyl 
sulfate treatment.  The first method, a 10% bleach solution for several minutes, was 
chosen because it is the traditional method for blood decontamination. Upon treatment of 
the solution with bleach, the solution color went from dark red to yellow. After 
centrifugation the supernatant was removed and saved for further analysis. The pellet was 
re-dispersed in water and exhibited a light pink color that resembled the color of the 
 
Figure 4.4. SERS Spectra of Recovered 
AuSRI@MS nanoparticles from human whole 
blood. 
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original nanoparticle solution. Both the supernatant and the re-dispersed pellet were 
studied using Raman spectroscopy. Neither solution showed any of the original MBA 
Raman shifts. It is our hypothesis that the surface chemistry of the nanoparticles was 
oxidized with the bleach treatment while the Au nanoparticles remained in tact (from 
TEM analysis, data not shown). In order to keep the surface chemistry of the 
nanoparticles in tact, an SDS treatment was performed (i.e. the same protocol of 
centrifugation and re-dispersion was performed with SDS). Following the SDS treatment 
(Figure 4.4) the supernatant did not exhibit any of the MBA Raman shifts, while the re-
dispersed pellet showed Raman shifts corresponding to MBA.  In future experiments, the 
stability of the particles will be examined in vivo using surface-enhanced spatially offset 
Raman spectroscopy (SESORS).   
Conclusions 
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 While this study provided insight into the stability of mesoporous silica coated 
AuNPs, these results represent one replicate of stability in blood over 100 days. Due to 
the nature of this collaboration between SRI and the Haynes research group, the details 
about different batches of AuSRI nanoparticles were unavailable.  
 
 
 
 
 
 
 
 
 
Figure 4.5. Stability of AUNP@@MBA@MS in human whole blood after 
100 days 
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Chapter 5. An Investigation of Mesogold with Smartphone Colorimetry and 
Google Applications  
 
 
5.1 Introduction 
Spectrophotometry and colorimetry experiments are common in many high school 
and college chemistry courses. In many of these experiments, students utilize 
spectrophotometers and colorimeters to obtain absorbance or color intensity data to 
determine the concentration of a colored analyte in solution. Recent changes in state and 
national science education standards have guided teachers towards inquiry-based lab 
activities to support learning of classroom curriculum. The addition of International 
Society for Technology in Education (ISTE) technology standards for teachers and 
students has generated a need for lab experiments that utilize technology.1 Recent 
teaching and learning models, such as Technological Pedagogical and Content 
Knowledge (TPACK), suggest that the use of technology combined with sound pedagogy 
and content knowledge improve student learning (tpack.org).2 Recently Kehoe and Penn 
published a method for performing quantitative colorimetry utilizing a camera capable 
device, such as a smartphone, in place more traditional spectrophotometric or 
colorimetric equipment.3 The use of smartphones coupled with data collection and 
analysis via Google applications can make sophisticated lab experiments more feasible, 
especially for teachers with limited budgets.4,5 Here we describe an inquiry-based 
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investigation of the concentration of a mesogold colloidal gold mineral supplement, a 
medicinal supplement that claims to improve motor skills.6 As smartphones and Google 
applications have become common tools for today’s students in their everyday lives, it is 
sensible to exploit the technological advantages of this ubiquitous technology in the 
classroom. This investigation addresses this opportunity while also facilitating study of 
nanoscience, a topic of emerging importance and popularity in chemistry education.  
5.2 Experimental Overview 
5.2.1 Preparation of chemicals for standard gold nanoparticle suspension 
Gold (III) chloride hydrate (10g, 484385 Sigma Aldrich, $394.50) and sodium citrate 
(1 kg, W302600, Sigma Aldrich, $68.00) were purchased and used as received. A 1.0 
mM gold chloride solution was prepared by dissolving 0.200 g in enough Milli-Q water 
to produce 1.00 L of solution using a volumetric flask. A 38.8 mM sodium citrate 
solution was prepared by dissolving 2.00 g in enough Milli-Q water to produce 200 mL 
of solution using a volumetric flask.  
5.2.2 Experiment 
The MesoGold Colloidal Gold mineral supplement that students were given to 
analyze claims to have a concentration of at least 20 ppm gold particles, as indicated on 
the supplement’s bottle and the distributor’s website. Students were given the task of 
determining the concentration of gold nanoparticles in the supplement as well as the 
monetary value of the gold in a 250 mL bottle based on the determined concentration. 
The students synthesized a standard gold nanoparticle solution with a concentration of 
100 ppm and then carried out a serial dilution with a dilution factor of one half down to at 
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least 6.25 ppm for calibration curve measurements. The students collected color intensity 
data to determine the absorbance of the gold nanoparticles in the standard solutions and 
the mineral supplement following Kehoe and Penn’s methods for analysis.3 Through a 
Beer’s Law plot of the standard solutions, the students determined the concentration of 
the mineral supplement. 
5.2.3 Preparation of 100 ppm standard gold nanoparticle solution 
New or glassware cleaned with aqua regia is preferred, but not necessary as 
indicated by previous publication.7 20.0 mL of 1.0 mM gold (III) chloride stock solution 
was measured using a disposable 20 mL plastic pipet tip with rubber bulb and placed in a 
125 mL Erlenmeyer flask. The solution was brought to 100.0 oC on a hot plate while 
stirring. As the solution began to boil, 2.0 mL of 38.8 mM sodium citrate stock solution 
was added using a disposable 10 mL plastic pipet tip with rubber bulb. The solution was 
allowed to continue boiling until a ruby red color was observed. The solution was 
removed from the heat and allowed to cool to room temperature. The solution volume 
was brought to 22 mL by addition of Milli-Q water to account for evaporative loss to 
bring the final solution concentration to 100 ppm.  
5.3 Data Collection 
The students photographed their dilution series along with a blank sample and a 
MesoGold Colloidal Gold Mineral Supplement sample in polystyrene cuvettes with a 
smartphone (Figure 1). Students adjusted the location and lighting in attempt to minimize 
shadows. The students used a free color picker application of their choice to collect three 
green intensity values from each sample. The students only used the green channel as it is 
 
 
 87 
 
the most complementary to the red colored solutions and thus would yield the most 
quantitative results.3  
 
Figure 5.1. Photograph of 50 ppm, 25 ppm, 12.5 ppm, and 6.25 ppm standards, blank, 
and MesoGold sample respectively. 
 
5.4 Data Analysis 
The concentrations of the solutions and green intensity values collected from each 
group were entered into a Google Spreadsheet shared amongst the members of the group. 
An average green intensity was calculated and translated into an absorbance value using 
the spreadsheet tools and Equation 1 where ! is the average green intensity of each 
standard solution and !! is the average green intensity of the blank. 
!"#$%"&'()! ! ! !!"#!!!!!! (Equation 1) 
The concentration and absorbance values were plotted. The students used the 
equation for the line of best fit to determine the concentration of the mesogold sample 
(Figure 2). 
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Figure 5.2. Sample student data analysis from the colorimetric smartphone method using 
a Google Spreadsheet.  
 
Following spreadsheet analysis, students generated collaborative lab reports using 
Google documents, while receiving timely instructor feedback through the commenting 
tool. Students shared their data and results with a broader audience of chemistry 
professionals and experts through Google hangouts. 
5.5 Hazards 
Gold chloride may be harmful if swallowed or inhaled and can cause irritation to the 
skin, eyes and respiratory tract. Skin contact with sodium citrate should be avoided as it 
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can cause irritation to the skin, eyes and respiratory tract. Nanoparticle solutions should 
be disposed of in accordance to local hazardous waste procedures. Safety glasses and 
gloves should be worn at all times. Clean up spills immediately and consult SDSs for 
complete safety information. Personal electronic devices, such as smartphones, may be 
placed inside clear plastic bags to limit contamination of devices with chemicals.  
5.6 Discussion 
12 of the 15 participating student groups successfully followed the experimental 
procedure and analysis. The average concentration of the MesoGold mineral supplement 
was determined to be 22 (±4) ppm by smartphone analysis with the advertised 
concentration of MesoGold as 20 ppm. The student groups that were unsuccessful in 
determining the concentration of mesogold by smartphone analysis had issues with dirty 
equipment, made mistakes in their dilution of the 100 ppm standard solution, or were 
unable to obtain a quality image for analysis. As previously published,3 images that yield 
the best results can be acquired by using an appropriately colored background, an image 
acquisition application that locks the focal plane of the camera, and by minimizing 
fluctuations of the ambient light. 
In Figure 2, representative data from the color picker app on a smartphone is 
represented. Google Spreadsheet offers the ability to calculate the calibration curve and 
correlation value for the line of best fit (in this classroom setting the students had access 
to Chromebooks). The functionality of Google Spreadsheet is adequate to perform the 
necessary analysis for these experiments, and more importantly can offer immediate 
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feedback to the students if their analysis is incorrect as teachers can respond to their 
analysis in real time. In addition, the ability to observe students performing data analysis 
in one shared space offers the ability to correctly assess the participation of a student 
working in a group. This also offers the students the opportunity to work collaboratively 
on a project online and contribute separately to the same document, which removes the 
ambiguity of assigning participation. In addition, students can work on separate aspects 
of the data analysis and check their work against other group members if they are unsure 
about the analysis. 
A template of the spreadsheet was provided to the students to teach the methods that 
are offered in Google Spreadsheet. While students performed the analysis with guidance 
from the template, they distributed their workload independently. Google also offers a 
streamlined approach to distributing the template to the students via Classroom.8 Google 
Classroom is available to educators with a Google Apps for Education account. 
5.7 Conclusion 
A camera capable device can be used to determine the concentration of mesogold in 
MesoGold Colloidal Gold Mineral Supplement. The combination of a camera capable 
device and free Google applications provides a unique and viable lab experience for high 
school and college chemistry students to explore fundamental chemistry concepts in the 
context of nanoscience. The use of Google applications facilitates efficient instruction 
and feedback between the students and teachers for effective collaboration. 
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5.8 Student Activity 
5.8.1 Objective: 
In this activity you will learn about nanoparticles, synthesize gold nanoparticles, and 
study the concentration of gold nanoparticles using a smartphone or tablet device. 
 
5.8.2 Learning about Nanoparticles 
 
5.8.2.1 Pre-Reading Questions: 
1. Where have you heard the term nano? 
 
2. What does the term nano mean to you? 
 
3. What do you know about nanoscience or nanomaterials? 
 
An Introduction to Nanoparticles: 
A nanoparticle is a nanoscale particle. One nanometer is 1 x 10-9 meters. To put this 
in perspective, one nanometer is 10,000 times smaller than the diameter of a single 
human hair.7 Nanoscience investigates the properties of nanomaterials. New and 
emerging applications for nanomaterials makes our understanding of them increasingly 
important. Nanoparticles can be found in paints, cosmetics, medicines, electronics, and 
food, and other places. While nanoparticles can be found in nature, but can also be 
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synthetically produced in laboratories. Transmission electron microscopes (TEM) are 
used to characterize the size and shape of nanoparticles.  
The physical properties of nanoparticles are size dependant. For example, a bulk 
sample of gold, such as in jewelry, appears yellow, but a solution of nano-sized gold 
particles can appear as a variety of colors depending on their size. The variation in color 
is a result of how the particles interact with light. Large particles interact with light 
differently than small particles. The chemical properties of nanoparticles are also size 
dependant. For example, small particles have high surface area, giving the particles 
potential for high reaction speeds.  
 
5.8.2.2 Post-Reading Questions: 
1. What is the relative size of a nanoparticle? 
 
2. How are nanoparticles characterized? 
 
3. Why is bulk gold yellow in color, but nano-sized gold not? 
 
4. What gives nanoparticles the potential for high speed of reaction? 
 
5. What are some of the current applications of nanoparticles? 
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5.8.3 Synthesis of Gold Nanoparticle Solution (100 ppm): 
 
5.8.3.1 Materials needed:  
• 20.0 mL of 1.0 mM gold chloride (AuCl3) stock solution 
• 2.0 mL of 38.8 mM sodium citrate (Na3C6H5O7•2H2O) stock solution 
• 125 mL Erlenmeyer flask 
• stir bar 
• stir/hot plate 
 
5.8.3.2 Procedure: 
• Add 20.0 mL of 1.0 mM gold chloride stock solution to a 125 mL Erlenmeyer 
flask. 
• Bring the gold chloride solution to a boil (100oC) while stirring on a hot plate.  
• As the solution begins to boil, add 2.0 mL of sodium citrate stock solution.  
• Continue to boil for 10 minutes or until a ruby red color has been observed.  
• Remove the solution from heat and allow it to cool to room temperature.  
• Bring solution volume to a total of 22 mL by addition of distilled water. (This will 
account for evaporative loss of water and will yield a final concentration of 100 
ppm.) 
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5.8.3.3 Observations and Lab Notes: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.8.3.4 Studying the Concentration of Gold Nanoparticles 
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5.8.3.5 Purpose:  
Using your 100 ppm sample of gold nanoparticles as a standard, determine the 
concentration of gold nanoparticles in MesoGold Colloidal Gold Mineral Supplement. 
 
What is MesoGold Colloidal Gold Mineral Supplement?: 
 
 
The following was taken from the World Wellness Store’s advertisement for 
MesoGold Colloidal Gold Mineral Supplement: 
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Colloidal gold is nanoparticles of pure gold suspended in pure water. The gold 
nanoparticles in MesoGold are a few nanometers in diameter. These particles are so small 
they can only be seen by the most powerful electron microscopes available today. These 
particles stay suspended in pure deionized water and do not fall to the bottom. It is these 
suspended particles that make MesoGold a true colloid. MesoGold is the most effective 
Colloidal Gold. Most products advertised as being colloidal gold are produced using an 
electrolysis process that produces gold particles that are typically 70-120 nanometers 
(nm) in diameter. These particles are very large compared to the nanoparticles in 
MesoGold. The much smaller size of the gold nanoparticles in MesoGold produce a 
much higher particle surface area than other brands. It is the particle surface area which 
determines the effectiveness of a colloid. 
 
Gold has been known through the ages to have a direct effect on the activities of the 
heart and helps to improve blood circulation. It is beneficial for rejuvenating sluggish 
organs, especially the brain and digestive system, and has been used in cases of glandular 
and nervous congestion and lack of coordination. The body's temperature stabilizing 
mechanism is restored to balance with gold, particularly in cases of chills, hot flashes, 
and night sweats. Colloidal gold has a balancing and harmonizing effect on all levels of 
body, mind, and spirit. It is used to improve mental attitude and emotional states. It has 
been reported to promote a feeling of increased energy, will power, mental focus, and 
libido. According to many studies, colloidal gold increases mental acuity and the ability 
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to concentrate. Colloidal gold is thought to strengthen mental function by increasing the 
conductivity between nerve endings in the body and on the surface of the brain. 
 
MesoGold should be taken in the morning on an empty stomach 15-20 minutes before 
eating for maximum absorption. The nominal adult dosage for MesoGold is one 
tablespoon (15mL) daily but optimum dosage must be determined for each individual. 
Most adults will find their optimum dosage will be between 1 and 4 tablespoons.  
 
5.8.3.6 Preparation of Standard Solutions for Calibration Curve: 
 
5.8.3.6.1 Background: 
A calibration curve is a method that can be used to determine the concentration of a 
substance in an unknown sample by comparison of the unknown sample to a set of 
standard solutions with known concentrations. Your 100 ppm gold nanoparticle solution 
will be diluted in order to prepare the standard solutions. Dilution involves reducing the 
concentration of a solution by adding a particular amount of distilled water to a particular 
amount of stock solution. To calculate how much stock solution and distilled water are 
required to make an amount of a less concentrated solution the dilution equation can be 
used: 
Equation 1: M1V1 = M2V2 
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where M1  is the molarity of the stock solution, V1 is the volume of the stock solution 
required to make the desired diluted solution, M2 is the molarity of the desired diluted 
solution, and V2 is the volume of the desired diluted solution. 
 
Example: If 4.0 mL of a 50 ppm solution is desired the amount of 100 ppm stock 
solution and distilled water can be calculated as follows: 
M1V1 = M2V2 
 
M1 = 100 ppm 
V1 = ? 
M2 = 50 ppm 
V2 = 4.0 mL 
 
100 ppm (V1) = 50 ppm (4.0 mL) 
V1 = 2.0 mL 
 
2.0 mL of the 100 ppm stock solution is needed to create a 50 ppm solution. To reach 
a total volume of 4.0 mL, 2.0 mL of distilled water must be added. 
 
A serial dilution involves using the previous diluted solution to make the next 
solution. Fill in the table below and then complete the serial dilution.  
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Table 1. Volumes of stock solution and distilled water for standard solutions 
 50 ppm 25 ppm 12.5 ppm 6.25 ppm 3.125 ppm 
Volume of Gold 
Nanoparticle 
Solution 
 
Volume of 
100 ppm 
Solution = 
2.0 mL 
Volume of 
50 ppm 
Solution = 
 
Volume of 
25 ppm 
Solution = 
 
Volume of 
12.5 ppm 
Solution = 
 
Volume of 
6.25 ppm 
Solution = 
 
Volume of 
distilled water 
 
2.0 mL 
    
Total volume 
 
4.0 mL 4.0 mL 4.0 mL 4.0 mL 4.0 mL 
 
5.8.3.6.2 Collection of Image to Determine Concentration of MesoGold: 
 
Procedure: 
1. Fill a cuvette with 2.0 mL of the 50 ppm solution. Repeat this with the other 
standard solutions, distilled water, and the unknown.  
2. Line up the cuvettes against a green or white background and foreground. 
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3. Position a smartphone or other camera capable device approximately 12 inches 
from the solutions. Adjust the positions of the solutions and smartphone or other 
device or the lighting to minimize shadows or glare in the images.  
4. Take an image 
 
5.8.3.6.3 Analysis of Image: 
 
Procedure: 
Analysis of the images with a color picker application can be completed on the 
smartphone or other camera capable device used for image collection or images can be 
transferred to a computer for analysis. To assist with data analysis an example data table 
and calculations are provide below. 
1. Starting with the 50 ppm solution, use a color picker application to measure the 
green color intensity at three locations in the sample.  
2. Repeat this for the 25 ppm solution, 12.5 ppm solution, 6.25 ppm solution, 3.125 
ppm solution, and blank.  
3. Calculate the average green color intensity for each solution and blank.  
4. Convert each of the average green color intensities to an absorbance using 
equation X.  
5. Prepare the calibration curve by plotting the absorbance versus concentration of 
each solution and blank.  
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6. Determine the slope and y-intercept for the line of best fit and put them into y = 
mx + b format. In this equation y represents the absorbance and x represents the 
concentration. This equation will allow for determining the concentration of the 
reaction mixture given an absorbance of the mixture at each time point. 
7. Starting with the image used for the calibration curve measure the green color 
intensity of the reaction mixture at three locations.  
8. Repeat this for each time point. 
9. Calculate the average green color intensity of the reaction mixture at each time 
point.  
10. Convert the average green color intensity from each time point to an absorbance 
using equation 6.  
11. Convert the absorbance values to concentration values using the equation 
determined by the calibration curve in step 7.  
12. Calculate ln(concentration) for each time point 
13. Calculate 1/(concentration for each time point.  
14. Construct three plots using Excel, Google spreadsheets, or a similar program:  
a. concentration versus time 
b. ln(concentration) versus time 
c. 1/(concentration) versus time 
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15. Assess the linearity of each plot to determine the integrated rate law and the order 
of the reaction with respect to crystal violet. A correlation coefficient (R2) may be 
useful in assessing the linearity of the plots. 
16. Construct a table similar to table 2. Example calculations can be found below. 
 
Table 2. Example data table 
Time 
(seco
nds) 
Measured 
Green Intensity 
#1 
Measured 
Green Intensity 
#2 
Measured 
Green Intensity 
#3 
Calculated 
Average 
Intensity 
Calculated 
Absorbance 
30 64 67 69 66.667 0.383 
40      
50      
...      
 
Example Calculations: 
Average Intensity: 
Average Intensity =Green Intensity #1 + Green Intensity #2 + Green Intensity #33= 
64 + 67 + 693=66.667 
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Absorbance: 
If the average green intensity of blank was 161 
Absorbance =-log(I/Io)=-log(66.667/161)=0.383 
 
Concentration: 
If the y = mx + b equation from calibration curve was y = 0.0503x + -0.0461 (where y 
is the absorbance and x is the concentration) 
0.383 =0.0503x+-0.0461 
x = 8.517 
 
5.8.4 Post-Lab Questions: 
1. Estimate the worth of the gold in the MesoGold supplement? 
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Chapter 6. Conclusions and Future Work 
 Raman spectroscopy applied to the forensic analysis of biological solutions 
including blood, urine, saliva, etc is an emerging field. In Chapter 1, the analysis of blood 
utilizing Raman spectroscopy was reviewed and featured because of the non-destructive 
method of analysis and the usefulness of Raman spectroscopy in forensic science as 
handheld Raman spectrometers are becoming commonplace. While Raman spectroscopy 
is known for a lack of sensitivity, creative sample preparations and the use of 
nanomaterials has allowed the field to continually improve in attempts to overcome the 
limited Raman scattering intensities. Chapter 2 detailed the work of utilizing nanoscaled 
materials to enhance the signal of Raman spectroscopy for the detection of a component 
of the cell-binding component of ricin in human whole blood. In addition to the detection 
of ricin B chain at a biologically relevant concentration, the work allowed for the 
improvement of AgFONs as a substrate. This improvement in substrates allowed for the 
development of the microfluidic-SERS devices in Chapter 3.  
The microfluidic-SERS devices performed remarkably well for the detection of BPE. 
While these devices were originally developed to be incorporated into the detection of 
ricin B chain in human blood, the aptamers that were used could not be observed in the 
channels of the device. This setback allowed for the development of nanoparticles that 
could be mixed with the biological solutions detailed in Chapter 4. Chapter 4 only details 
the beginning of this work and there is much left to be discovered. However, the 
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improvement of the stability of nanoparticles in biological solutions, while maintaining 
the ability to perform detection was proven in Chapter 4.    
In the fifth chapter, an outreach activity introducing nanomaterials was organized and 
conducted with an AP Chemistry class from White Bear Lake High School. This work 
elucidates the possibilities of nanoscience to be performed with high school students on a 
limited budget. The students overall response was positive and helped to introduce 
nanoscience to a new generation of future scientists. 
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Appendix B. Supporting Information Chapter 3.  
 
1. Supplemental Data 
 
Figure S-1. (a) Device design and (b) Fluorescence response analysis for intra-device 
variation assessment. 
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Figure S-2. 1 mM (a) BPE and (b) benzenethiol spectra obtained using the flexible SERS 
sensor prototype (i.e. with incorporated nanospheres). 
 
 
Figure S-3. Representative LSPR measurement performed on a AuNR-containing 
flexible SERS sensor. 
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Figure S-4. SERS response analysis before (a and c) and after (b and d) the use of a 
PDMS peak as an intensity correction standard. (a) and (b) are from AuNR flexible SERS 
sensors and (c) and (d) are from AuNC flexible SERS sensors. 
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Figure S-5",MATLAB baseline fit (green line) of a BPE spectrum (red line) of a 10 nm 
solution of BPE.  The peaks at 1610 and 1640 wavenumbers are not correctly resolved 
because of the overlapping nature of the peaks.  The baseline fit of the peaks is not 
accurately fitting both peaks and therefore skews the area under the curve and does not 
yield the correct response.  *Note: The x-axis was programmed to give the pixel number 
instead of the relative Raman shift in wavenumbers, however adding 200 to the x-axis 
gives the relative wavenumbers.!!!!
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Figure S-6. SEM image of the cross-section view of the AuFON before incorporation 
with a PDMS microfluidic device.  
 
2. Au nanosphere synthesis 
Au nanospheres (AuNSs) for use in initial flexible SERS devices were synthesized under 
a nitrogen atmosphere while sonicating (Branson, Model 2510) using equimolar amounts 
of aqueous hydrogen tetrachloroaurate and sodium citrate for half an hour.  The resulting 
purple solution was aged in the dark for 16 hours, with a final %max of 524 nm.1 
3. Enhancement factor calculation 
Enhancement factor calculation followed the method published by Wustholz et al (Eq. 
1).2 
!"#$"%&'&"(!!"#$%&! !" ! ! !!"#! !!!"#!!!"#!!! !!!"# !!!!!!!!!!!!!!!!!!!!!!!!!!!!"! !! 
where NNRS is the number of analyte molecules contributing to the normal Raman 
scattering measurement, NSERS is the number of analyte molecules contributing to the 
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SERS measurement, INRS is the normal Raman scattering intensity of the analyte at a 
particular cm-1 shift, and ISERS is SERS intensity of the analyte at an analogous cm-1 shift. 
In this calculation, we assume all molecules in the probe volume contribute equally to the 
measured signal. The value of NSERS was estimated two different ways to account for 
potential variations in nanoparticle distribution in the PDMS layer: (1) uniformly using 
the in-device probe volume, considering excitation laser spot size (25-µm-diameter) and 
the microfluidic channel heights (100 µm) and (2) based on the nanoparticle coverage 
seen in the figure 4 SEM image (assuming that this coverage is representative and that 
the revealed nanoparticle surface area is hemispherical). Calculating the enhancement 
factor both ways presents a reasonable enhancement factor range for the flexible SERS 
microfluidic device. For the simple consideration of all molecules in the cylindrical probe 
volume experiencing enhancement (estimation #1): the laser spot size for SERS 
measurement (25-(m-diameter) was 490.9 (m2 and the height of the microfluidic 
channel was 100 (m, yielding a probe volume (disregarding the possibility of sub-
monolayer nanoparticle coverage) is: !"#!!!!!!! !!""!!! ! !!!!!"!!!!! 
Using this probe volume: 
 !!"#! ! !!!! !!"!!!!!! ! !"!! ! !!!!!!!! !!! !!"!!! "#$!"!!! ! !!!!!"! !!"!" !"#$%&#$'!"#$ !!!!! !!"!"!"#$%&#$' 
Using the SEM image in figure 4 and ImageJ software to calculate nanoparticle surface 
coverage (estimation #2): the nanoparticle surface area is 325.4 nm2, and assuming each 
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nanoparticle presents a hemispherical surface protruding from the PDMS layer, we have 
a nanoparticle surface area within this imaged region of 650.8 nm2. With a total imaged 
area of 4,385,700 nm2, this yields a surface coverage of nanoparticles on the PDMS 
surface of 0.014%. With the laser spot size of 490.9 (m2, the surface area of 
nanoparticles within the excitation laser spot is: ! !"#!!!!!!!!!!!!"# ! !!!"#!!!! 
Assuming, optimistically, that all BPE molecules in the microfluidic channel can interact 
with the nanoparticles, we can get an estimated cylindrical probe volume of: ! !!!!"#!!!!!!""!!! ! !!!!!!! 
Thus, 
!!"#! ! !!!!!!!!! !"!! !! !!!!!! !!! !!"!!! "#$!"!!! ! !!!!!"! !!"!"!"#$%&#$'!"#$! !!!! !!"!!"#$%&#$' 
So, for the two assumptions, the number of molecules contributing to the measured SERS 
intensities range from 4.1 x 106 to 2.9 x 1010. ISERS for the 1200 cm-1 shift band, collected 
at 3 mW incident power for 10 seconds (matched to collection conditions for normal 
Raman spectra), was measured to be 4813 adus.  
 
For normal Raman measurement on a 100 mM BPE solution, probe volume was 
determined using the scanning knife edge method3 to be 0.0024 mm3, and thus: 
 !!"# ! !!!! !!"!" 
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!!"# ! !"#$ adus 
Thus, our estimated EF range for nanoparticles within the microfluidic device is:  
!" ! ! !!!! !!"!"! "#$%&#$' ! !"#$!!"#$!!!! !!"!!!!"!!!!! !!"!"! "#$%&#$' !! !"#$!!"#$ ! !!!!!"!!!!!!!"! 
 
(1)  Love, S. A.; Haynes, C. L. Anal Bioanal Chem 2010, 398, 677–688. 
(2)  Wustholz, K. L.; Henry, A.-I.; McMahon, J. M.; Freeman, R. G.; Valley, N.; Piotti, 
M. E.; Natan, M. J.; Schatz, G. C.; Van Duyne, R. P.  J. Am. Chem. Soc. 2010, 132, 
10903-10910. 
(3) Wustholz, K. L.; Henry, A.-I.; McMahon, J. M.; Freeman, R. G.; Valley, N.; 
Piotti, M. E.; Natan, M. J.; Schatz, G. C.; Van Duyne, R. P. J. Am. Chem. Soc. 2010, 132, 
10903–10910. 
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Appendix C. Python Coding for Principle Component Analysis 
######################################################################
########## 
#   Copyright M. G. Blaber 2011, Edited and Updated A.R. Campos 2015 
#   This file is part of SFP = Street Fighting Plasmonics 
#   Street Fighting Plasmonics is free software: you can redistribute it  
#   and/or modify it under the terms of the GNU General Public License as 
#   published by the Free Software Foundation, either version 3 of the  
#   License, or (at your option) any later version. 
# 
#   Foobar is distributed in the hope that it will be useful, 
#   but WITHOUT ANY WARRANTY; without even the implied warranty of 
#   MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.  See the 
#   GNU General Public License for more details. 
# 
#   You should have received a copy of the GNU General Public License 
#   along with SFP.  If not, see <http://www.gnu.org/licenses/>. 
######################################################################
########## 
#  
# SFP_SERS_barcode.py 
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#  version 0.03 
######################################################################
########## 
#Strings 
import string 
 
#Science 
import numpy 
from numpy import * 
from numpy.random import randn 
from scipy.interpolate import * 
 
#System 
import sys, os 
 
#Plotting 
import matplotlib 
import matplotlib.cm as cm 
import matplotlib.pyplot as plt 
from mpl_toolkits.mplot3d import Axes3D 
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#Local 
from subroutines import readfile, normalize, func_deriv, smooth, remove_cosmic_rays 
######################################################################
########## 
 
#Parameters 
min_cm=200 
max_cm=2000 
 
variance_to_explain=0.999 
 
#Setup Fonts for plots etc 
matplotlib.rcParams['font.size'] = 12 
label_font_size=16 
tick_font_size=12 
 
lw=4.0 #Line Width 
use_colormap   =True  #If this is set to false the colormap turns into a rainbow. 
rainbow_multiplier=10 #This number should be lower for larger numbers of spectra. 
 
#2D Plots of data prior to PCA. 
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figure_size=(8,10) #Inches 
plot_ysmooth   =True 
plot_dysmooth  =False 
plot_dydysmooth=True 
plot_binary    =True 
 
#3D Plots of PCA 
pca_figure_size=(10,8) 
plot_pca123    =True 
plot_pca234    =True 
include_3d_labels =False #This numbers each of the points in the 3d plot. 
#2d PCA plots. 
plot_eigenvectors=False #This are plots of the bits of the spectra which are important. 
plot_pca2d=True #Plot 6 2d plots: 1vs2, 1vs3  
 
 
######################################################################
########## 
#Find all of the files in the data directory. 
print "Finding data files" 
istep=0 
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datalist=[] 
for datfile in os.listdir("./data/"): 
    if (datfile[0] != "."): 
        if os.path.isfile("./data/"+datfile): 
            datalist.append("./data/"+datfile) 
        #endif  
    #if 
#next folder 
 
#Number of datasets 
ndatafiles=len(datalist) 
print "Number of datasets = %d"%(ndatafiles) 
 
######################################################################
########## 
#Sort out color table and assign colors to files 
print "Organizing Colors" 
#To edit these colors, visit: http://www.colorpicker.com/ 
#Color Look up table: 
my_colors={ # string_in_filename:Color 
    "dred":"#A10C01",  
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    "lred":"#FF8BA9", 
    "lorange":"#FF8615", 
    "dorange":"#D43400", 
    "lgreen":"#26D800", 
    "dgreen":"#257600", 
    "lblue":"DodgerBlue", 
    "dblue":"DarkBlue", 
    "lpurple":"#CC49EB", 
    "dpurple":"#6424C3" 
} 
 
color_data=['']*ndatafiles # Cell type stores the color information for each file. 
for id in range(ndatafiles): 
    color_label=datalist[id].replace('./data/','').split('_')[0] 
    if not color_label[0]==".": 
        try: 
            color_data[id]=my_colors[color_label] 
        except: 
            print "Oops! There is no valid color identifier in %s. The Color label found is 
""%s"" "%(datalist[id],color_label) 
            raise 
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        #try 
    #if 
#for 
 
#Define Rainbow Spectra: 
rainbow_data=['']*ndatafiles 
for id in range(ndatafiles): 
    rainbow_data[id]=cm.Set1(id*rainbow_multiplier) 
#for 
 
#################################### 
#Save the list of filenames and colors to disk 
print "Saving list of filenames and colors to disk" 
f=open("data_list.txt",'w') 
for id in range(ndatafiles): 
    f.write("%d %s %s\n"%(id,datalist[id],color_data[id])) 
#for 
f.close() 
 
######################################################################
########## 
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#Allocate Storage of raw dataset. 
 
ncm=1*int(max_cm-min_cm)+1 
xs = linspace(min_cm,max_cm, ncm) 
print "Interpolate data from %d cm-1 to %d cm-1 in %d 
steps"%(min_cm,max_cm,ncm) 
 
#STORAGE ARRAY 
print "Allocating the storage matrix" 
data_set=zeros((ndatafiles,ncm)) 
print "size(data_set) = ",shape(data_set) 
 
######################################################################
########## 
 
 
id=-1 
for datfile in datalist: 
     
    id+=1 
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    print "%5d%5d %s"%(id,ndatafiles,datalist[id].replace('./data/','')) 
     
    #Read the data file. 1 and 2 are the column numbers that are being read. 
    raw_data=readfile(datalist[id],1,2) 
     
    #if this is the first id, then allocate the x and y arrays 
    if(id == 0 ): 
        nrawx=len(raw_data) 
        rawx=zeros([ndatafiles,nrawx]) 
        rawy=zeros([ndatafiles,nrawx]) 
        y_raw_smooth=zeros([ndatafiles,nrawx]) 
        y_smooth=zeros([ndatafiles,ncm]) 
        dy_smooth=zeros([ndatafiles,ncm]) 
        dydy_smooth=zeros([ndatafiles,ncm]) 
    #if 
     
    #Save the Raw data 
    for ix in range(nrawx): 
        rawx[id,ix]=raw_data[ix,0] 
        rawy[id,ix]=raw_data[ix,1] 
    #for 
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    #Remove Cosmic Rays. If you still have cosmic rays. Try decreasing max_diff. 
    remove_cosmic_rays(rawy[id,:],max_diff=2) 
     
    #Normalize The Data 
    normalize(rawy[id,:]) 
     
    #smooth data 
    y_raw_smooth[id,:]=smooth(rawy[id,:],window_len=20,window='hanning') 
     
    #Create a function describing the smoothed y data. 
    y_smooth_f = UnivariateSpline(rawx[id,:],y_raw_smooth[id,:],s=0.000001) 
    #Create an array containing the smoothed data 
    y_smooth[id,:]=y_smooth_f(xs) 
     
    #Perform the first derivative calculation 
    for icm in range(ncm): 
        dy_smooth[id,icm] = func_deriv(y_smooth_f,xs[icm]) 
    #for 
     
    #smooth data 
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    #dy_smooth[id,:]=smooth(dy_smooth[id,:],window_len=50,window='hanning') 
     
     
    #interpolate the dy_smooth 
    dy_smooth_f = UnivariateSpline(xs[:],dy_smooth[id,:],s=0.000001) 
     
    #Perform the second derivative calculation 
    for icm in range(ncm): 
        dydy_smooth[id,icm] = func_deriv(dy_smooth_f,xs[icm]) 
    #for 
     
    #smooth data 
    #dydy_smooth[id,:]=smooth(dydy_smooth[id,:],window_len=50,window='hanning') 
     
    #Save the interpolated data. 
    for icm in range(ncm): 
        data_set[id,icm]=sign(dydy_smooth[id,icm])/2.0 
    #for 
     
#next datafile 
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print "Done Reading Data Files" 
 
######################################################################
########## 
######################################################################
########## 
 
 
if (plot_ysmooth): 
    plt.figure(1, figsize=figure_size, dpi=96, facecolor='w', edgecolor='k') 
    plt.ylabel('Smoothed Intensity',fontsize=label_font_size) 
    plt.xlabel('Wavenumber (cm^-1)',fontsize=label_font_size) 
    for id in range(ndatafiles): 
        mc=color_data[id] if use_colormap == True else rainbow_data[id] 
        plt.plot(rawx[id,:],y_raw_smooth[id,:]+(id),c=mc,linewidth=lw,label="id 
%d"%id) 
    #next plot 
    plt.legend(loc='best') 
    plt.savefig('figures/PCA_YSmooth.png',dpi=300) 
    plt.savefig('figures/PCA_YSmooth.pdf') 
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    plt.show() 
######################################################################
########## 
if (plot_dysmooth): 
    plt.figure(2, figsize=figure_size, dpi=96, facecolor='w', edgecolor='k') 
    plt.ylabel('First Derivative',fontsize=label_font_size) 
    plt.xlabel('Wavenumber (cm^-1)',fontsize=label_font_size) 
    for id in range(ndatafiles): 
        mc=color_data[id] if use_colormap == True else rainbow_data[id] 
        plt.plot(xs[:],dy_smooth[id,:]+(id)/30.0,c=mc,linewidth=lw,label="id %d"%id) 
    #next plot 
    plt.legend(loc='best') 
    plt.savefig('figures/PCA_dYSmooth.png',dpi=300) 
    plt.savefig('figures/PCA_dYSmooth.pdf') 
    plt.show() 
#if 
######################################################################
########## 
if (plot_dydysmooth): 
    plt.figure(2, figsize=figure_size, dpi=96, facecolor='w', edgecolor='k') 
    plt.ylabel('Second Derivative',fontsize=label_font_size) 
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    plt.xlabel('Wavenumber (cm^-1)',fontsize=label_font_size) 
    for id in range(ndatafiles): 
        mc=color_data[id] if use_colormap == True else rainbow_data[id] 
        plt.plot(xs[:],dydy_smooth[id,:]+(id)/80.0,c=mc,linewidth=lw,label="id %d"%id) 
    #next plot 
    plt.legend(loc='best') 
    plt.savefig('figures/PCA_dYdYSmooth.png',dpi=300) 
    plt.savefig('figures/PCA_dYdYSmooth.pdf') 
    plt.show() 
#fi 
######################################################################
########## 
if (plot_binary): 
    plt.figure(2, figsize=figure_size, dpi=96, facecolor='w', edgecolor='k') 
    plt.ylabel('Binary',fontsize=label_font_size) 
    plt.xlabel('Wavenumber (cm^-1)',fontsize=label_font_size) 
    for id in range(ndatafiles): 
        mc=color_data[id] if use_colormap == True else rainbow_data[id] 
        offset=5.0*std(data_set[id,:]) 
        plt.plot(xs[:],data_set[id,:]+offset*id,c=mc,linewidth=0.5*lw,label="id %d"%id) 
    #next plot 
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    plt.legend(loc='best') 
    plt.savefig('figures/PCA_Binary.png',dpi=300) 
    plt.savefig('figures/PCA_Binary.pdf') 
    plt.show() 
#fi 
 
 
 
######################################################################
########## 
######################################################################
########## 
print "----------------------------------------------------------------------" 
print "Starting PCA" 
 
import pca 
 
#Normalize the data 
data_set -= data_set.mean() / data_set.std() 
 
#Perform the Single Value Decomposition. 
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p = pca.PCA(data_set, fraction=variance_to_explain ) 
 
######################################################################
########## 
print "Number of PCs = %d"%(p.npc) 
 
#print the eigenvalues an the sum of the variance. 
#Only the first 3 or 4 numbers are important. 
print "%3s%20s%20s"%("i","EigenValue","Sum of Variance")  
for i in range (p.npc): 
  print "%3d%20.5f%20.5f"%(i,p.eigen[i],p.sumvariance[i]) 
#for 
 
pcs = p.pc()  # d' Vt' x 
 
nobs,nvars=data_set.shape 
print "Shape of Data, nobs, nvars = ", nobs,nvars 
 
nobs,npcs=pcs.shape 
print "Shape of pcs, npcs, nvars = ", npcs,nobs 
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#Plot Principal Components 1-3 
if (plot_pca123): 
    fig=plt.figure(6, figsize=pca_figure_size, dpi=96, facecolor='w', edgecolor='k') 
    ax = fig.gca(projection='3d') 
    mc=color_data if use_colormap == True else rainbow_data 
    ax.scatter(pcs[:,0],pcs[:,1],pcs[:,2], c=mc, marker='o',s=100.0) 
    if(include_3d_labels): 
        for i in range(len(pcs[:,0])): 
            ax.text(pcs[i,0],pcs[i,1],pcs[i,2], "%d"%i, color='black',fontsize=12) 
        #for 
    #if 
    plt.xticks(fontsize=tick_font_size+4) 
    plt.yticks(fontsize=tick_font_size+4) 
    ax.set_xlabel('PC 1',fontsize=label_font_size) 
    ax.set_ylabel('PC 2',fontsize=label_font_size) 
    ax.set_zlabel('PC 3',fontsize=label_font_size) 
    plt.savefig('figures/3D_PC123.pdf') 
    plt.savefig('figures/3D_PC123.png',dpi=600) 
    plt.show() 
#IF 
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#Plot Principal Components 2-4 
if (plot_pca234): 
    fig=plt.figure(7, figsize=pca_figure_size, dpi=96, facecolor='w', edgecolor='k') 
    ax = fig.gca(projection='3d') 
    mc=color_data if use_colormap == True else rainbow_data 
    ax.scatter(pcs[:,1],pcs[:,2],pcs[:,3], c=mc, marker='o',s=100.0) 
    if(include_3d_labels): 
        for i in range(len(pcs[:,0])): 
            ax.text(pcs[i,1],pcs[i,2],pcs[i,3], "%d"%i, color='black',fontsize=12) 
        #for 
    #if 
    plt.xticks(fontsize=tick_font_size+4) 
    plt.yticks(fontsize=tick_font_size+4) 
    ax.set_xlabel('PC 2',fontsize=label_font_size) 
    ax.set_ylabel('PC 3',fontsize=label_font_size) 
    ax.set_zlabel('PC 4',fontsize=label_font_size) 
    plt.savefig('figures/3D_PC234.pdf') 
    plt.savefig('figures/3D_PC234.png',dpi=600) 
    plt.show() 
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#IF 
 
#Plot eigenvectors of PCA. 
if (plot_eigenvectors): 
    plt.figure(2, figsize=figure_size, dpi=96, facecolor='w', edgecolor='k') 
    plt.ylabel('Eigenvector',fontsize=label_font_size) 
    plt.xlabel('Wavenumber (cm^-1)',fontsize=label_font_size) 
    #plt=pylab.scatter(pcs[:,1],pcs[:,2],marker='+',s=400) 
    for ipc in range(npcs): 
        mc=rainbow_data[ipc] 
        offset=5.0*std(p.Vt[ipc]) 
        plt.plot(xs[:],p.Vt[ipc]+offset*ipc,c=mc,linewidth=lw/2.0,label="PC 
%d"%(ipc+1)) 
    #for 
    plt.xlim( (min_cm, max_cm) ) 
    plt.xticks(fontsize=tick_font_size) 
    plt.yticks(fontsize=tick_font_size) 
    #plt.legend() 
    plt.legend(loc='best') 
    plt.savefig('figures/PCA_Eigenvectors.png',dpi=300) 
    plt.savefig('figures/PCA_Eigenvectors.pdf') 
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    plt.show() 
#IF 
 
if (plot_pca2d): 
    fig=plt.figure(9, figsize=(12,8), dpi=96, facecolor='w', edgecolor='k') 
    fig.subplots_adjust(left=0.08,right=0.95,wspace = 0.4,hspace=0.2) 
    sp=[231,232,233,234,235,236] 
    xl=[1,1,1,2,2,3] 
    yl=[2,3,4,3,4,4] 
    ax=['']*6 
    for ip in range(6): 
        print ip,sp[ip] 
        ax[ip]=fig.add_subplot(sp[ip]) 
        ax[ip].set_xlabel('PC%1d'%xl[ip],fontsize=label_font_size) 
        ax[ip].set_ylabel('PC%1d'%yl[ip],fontsize=label_font_size) 
        mc=color_data if use_colormap == True else rainbow_data 
        ax[ip].scatter(pcs[:,xl[ip]-1],pcs[:,yl[ip]-1], c=mc, marker='o',s=100.0) 
    #next plot 
    plt.savefig('figures/PCA_2D.png',dpi=300) 
    plt.savefig('figures/PCA_2D.pdf') 
    plt.show() 
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#fi 
 
 
 
out_file = open("barcode-eigenvectors.dat", 'w') 
for i in range(len(xs)): 
    out_file.write("%f %f %f %f %f 
%f\n"%(xs[i],p.Vt[0,i],p.Vt[1,i],p.Vt[2,i],p.Vt[3,i],p.Vt[4,i])) 
out_file.close() 
 
out_file = open("barcode-eigenvalues.dat", 'w') 
for i in range(len(datalist)): 
    out_file.write("%d %s %f %f %f 
%f\n"%(i,datalist[i],pcs[i,0],pcs[i,1],pcs[i,2],pcs[i,3])) 
out_file.close() 
 
sys.exit() 
Sub Routines 
######################################################################
########## 
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import numpy 
from numpy import zeros,concatenate 
debug=False 
######################################################################
########## 
 
def readfile(filename, colx, coly): 
 
    in_data=zeros((0,2)) 
 
#This is pretty much the fastest way possible to read a file. 
    file = open(filename) 
    iline=0 
    idataline=0 
    for line in file: 
        if " " in line: 
            splitter=" " 
        elif "," in line: 
            splitter="," 
        #if 
        iline=iline+1 
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        s=line.strip().split(splitter) 
        if(len(s)!=0): 
            char1=s[0][0] 
            if ( char1 == "#" or char1 == "!" or char1=="%" or char1=="W" ): 
                #print("%s"%(line)) 
                donothing=1 #This is a placeholder. It  does nothing.. 
            else: 
                #Make sure there are enough columns on this line 
                if (len(s) < max(colx,coly) ): 
                    print "Error on line %d. Not enough columns"%(iline) 
                else: 
                    idataline=idataline+1 
                    in_data=concatenate( ( in_data, [[float(s[colx-1]),float(s[coly-1])]] ) ) 
                #if 
            #if 
        #if 
    #for 
 
    ndata=len(in_data) 
    if(debug): 
        print "Length of the file in lines = %d"%(iline) 
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        print "%7d:%14.8f %14.8f"%(0,in_data[0][0],in_data[0][1]) 
        print "%7d:%14.8f %14.8f"%(ndata,in_data[ndata-1][0],in_data[ndata-1][1]) 
    #if 
     
    return in_data 
     
#end function 
 
######################################################################
########## 
 
def normalize(data): 
    maxy=max(data[:]) 
    miny=min(data[:]) 
    norm_factor=maxy-miny 
    for ix in range(len(data)): 
        data[ix]=(data[ix]-miny)/norm_factor-0.5 
    #for 
     
#def 
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######################################################################
########## 
 
def func_deriv(f,x): 
    #F is the function we're taking the derivative of, x is the parameter to give to f. 
    # A ... X ... B 
    dyb=0 
    dya=5 
    dx=0.002 
    iloop=0 
    while(abs(abs(dyb)-abs(dya))>0.001): 
        dx=dx/2.0 
         
        xa=x-dx 
        xb=x+dx 
     
        ya=f(xa) 
        y=f(x) 
        yb=f(xb) 
     
        dya=y-ya 
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        dyb=yb-y 
         
        iloop=iloop+1 
         
        if (iloop>10): 
            print "Derivative does not converge" 
            return nan 
        #if 
         
    #while 
     
    return (dya/dx+dyb/dx)/2.0 
#def func_deriv 
 
######################################################################
########## 
 
def remove_cosmic_rays(x,max_diff=10): 
     
     
    if x.ndim != 1: 
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        raise ValueError, "smooth only accepts 1 dimension arrays." 
     
    nx=len(x) 
     
    stdev=numpy.std(x) 
    #print stdev 
     
    for i in range(1,nx): 
        if ( abs(x[i]-x[i-1])>max_diff*stdev ): 
            x[i]=x[i-1] 
        #if 
    #for 
     
#end function 
 
######################################################################
########## 
 
def smooth(x,window_len=10,window='hanning'): 
    """smooth the data using a window with requested size. 
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    This method is based on the convolution of a scaled window with the signal. 
    The signal is prepared by introducing reflected copies of the signal  
    (with the window size) in both ends so that transient parts are minimized 
    in the begining and end part of the output signal. 
     
    input: 
        x: the input signal  
        window_len: the dimension of the smoothing window; should be an odd integer 
        window: the type of window from 'flat', 'hanning', 'hamming', 'bartlett', 'blackman' 
            flat window will produce a moving average smoothing. 
 
    output: 
        the smoothed signal 
         
    example: 
 
    t=linspace(-2,2,0.1) 
    x=sin(t)+randn(len(t))*0.1 
    y=smooth(x) 
     
    see also:  
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    numpy.hanning, numpy.hamming, numpy.bartlett, numpy.blackman, 
numpy.convolve 
    scipy.signal.lfilter 
  
    TODO: the window parameter could be the window itself if an array instead of a 
string    
    """ 
 
    if x.ndim != 1: 
        raise ValueError, "smooth only accepts 1 dimension arrays." 
 
    if x.size < window_len: 
        raise ValueError, "Input vector needs to be bigger than window size." 
 
 
    if window_len<3: 
        return x 
 
 
    if not window in ['flat', 'hanning', 'hamming', 'bartlett', 'blackman']: 
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        raise ValueError, "Window is on of 'flat', 'hanning', 'hamming', 'bartlett', 
'blackman'" 
 
    x0=x[window_len-1:0:-1] 
    xn=x[-1:-window_len:-1] 
    s=numpy.r_[x0,x,xn] 
    #print(len(s)) 
    if window == 'flat': #moving average 
        w=numpy.ones(window_len,'d') 
    else: 
        w=eval('numpy.'+window+'(window_len)') 
     
    y=numpy.convolve(w/w.sum(),s,mode='valid') 
     
    #print "x0 = ",len(x0) 
    #print "x  = ",len(x) 
    #print "xn = ",len(xn) 
    #print "y  = ",len(y) 
    lx0=len(x0) 
    if lx0 % 2 != 0: 
        lx0=lx0+1 
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    #if 
    #print "x0 = ",lx0 
    ly=len(y) 
    y=y[lx0/2:ly-len(xn)/2] 
     
    #print "y  = ",len(y) 
     
    return y 
 
#end function 
Principle Component Analysis 
#!/usr/bin/env python 
""" a small class for Principal Component Analysis 
Usage: 
    p = PCA( A, fraction=0.90 ) 
In: 
    A: an array of e.g. 1000 observations x 20 variables, 1000 rows x 20 columns 
    fraction: use principal components that account for e.g. 
        90 % of the total variance 
 
Out: 
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    p.U, p.d, p.Vt: from numpy.linalg.svd, A = U . d . Vt 
    p.dinv: 1/d or 0, see NR 
    p.eigen: the eigenvalues of A*A, in decreasing order (p.d**2). 
        eigen[j] / eigen.sum() is variable j's fraction of the total variance; 
        look at the first few eigen[] to see how many PCs get to 90 %, 95 % ... 
    p.npc: number of principal components, 
        e.g. 2 if the top 2 eigenvalues are >= `fraction` of the total. 
        It's ok to change this; methods use the current value. 
 
Methods: 
    The methods of class PCA transform vectors or arrays of e.g. 
    20 variables, 2 principal components and 1000 observations, 
    using partial matrices U' d' Vt', parts of the full U d Vt: 
    A ~ U' . d' . Vt' where e.g. 
        U' is 1000 x 2 
        d' is diag([ d0, d1 ]), the 2 largest singular values 
        Vt' is 2 x 20.  Dropping the primes, 
 
    d . Vt      2 principal vars = p.vars_pc( 20 vars ) 
    U           1000 obs = p.pc_obs( 2 principal vars ) 
    U . d . Vt  1000 obs, p.obs( 20 vars ) = pc_obs( vars_pc( vars )) 
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        fast approximate A . vars, using the `npc` principal components 
 
    Ut              2 pcs = p.obs_pc( 1000 obs ) 
    V . dinv        20 vars = p.pc_vars( 2 principal vars ) 
    V . dinv . Ut   20 vars, p.vars( 1000 obs ) = pc_vars( obs_pc( obs )), 
        fast approximate Ainverse . obs: vars that give ~ those obs. 
 
 
Notes: 
    PCA does not center or scale A; you usually want to first 
        A -= A.mean(A, axis=0) 
        A /= A.std(A, axis=0) 
    with the little class Center or the like, below. 
 
See also: 
    http://en.wikipedia.org/wiki/Principal_component_analysis 
    http://en.wikipedia.org/wiki/Singular_value_decomposition 
    Press et al., Numerical Recipes (2 or 3 ed), SVD 
    PCA micro-tutorial 
    iris-pca .py .png 
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""" 
 
from __future__ import division 
import numpy as np 
dot = np.dot 
    # import bz.numpyutil as nu 
    # dot = nu.pdot 
 
__version__ = "2010-04-14 apr" 
__author_email__ = "denis-bz-py at t-online dot de" 
 
#............................................................................... 
class PCA: 
    def __init__( self, A, fraction=0.90 ): 
        assert 0 <= fraction <= 1 
        # A = U . diag(d) . Vt, O( m n^2 ), lapack_lite -- 
        self.U, self.d, self.Vt = np.linalg.svd( A, full_matrices=False ) 
        assert np.all( self.d[:-1] >= self.d[1:] )  # sorted 
        self.eigen = self.d**2 
        self.sumvariance = np.cumsum(self.eigen) 
        self.sumvariance /= self.sumvariance[-1] 
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        self.npc = np.searchsorted( self.sumvariance, fraction ) + 1 
        self.dinv = np.array([ 1/d if d > self.d[0] * 1e-6  else 0 
                                for d in self.d ]) 
 
    def pc( self ): 
        """ e.g. 1000 x 2 U[:, :npc] * d[:npc], to plot etc. """ 
        n = self.npc 
        return self.U[:, :n] * self.d[:n] 
 
    # These 1-line methods may not be worth the bother; 
    # then use U d Vt directly -- 
 
    def vars_pc( self, x ): 
        n = self.npc 
        return self.d[:n] * dot( self.Vt[:n], x.T ).T  # 20 vars -> 2 principal 
 
    def pc_vars( self, p ): 
        n = self.npc 
        return dot( self.Vt[:n].T, (self.dinv[:n] * p).T ) .T  # 2 PC -> 20 vars 
 
    def pc_obs( self, p ): 
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        n = self.npc 
        return dot( self.U[:, :n], p.T )  # 2 principal -> 1000 obs 
 
    def obs_pc( self, obs ): 
        n = self.npc 
        return dot( self.U[:, :n].T, obs ) .T  # 1000 obs -> 2 principal 
 
    def obs( self, x ): 
        return self.pc_obs( self.vars_pc(x) )  # 20 vars -> 2 principal -> 1000 obs 
 
    def vars( self, obs ): 
        return self.pc_vars( self.obs_pc(obs) )  # 1000 obs -> 2 principal -> 20 vars 
 
 
class Center: 
    """ A -= A.mean() /= A.std(), inplace -- use A.copy() if need be 
        uncenter(x) == original A . x 
    """ 
        # mttiw 
    def __init__( self, A, axis=0, scale=True, verbose=1 ): 
        self.mean = A.mean(axis=axis) 
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        if verbose: 
            print "Center -= A.mean:", self.mean 
        A -= self.mean 
        if scale: 
            std = A.std(axis=axis) 
            self.std = np.where( std, std, 1. ) 
            if verbose: 
                print "Center /= A.std:", self.std 
            A /= self.std 
        else: 
            self.std = np.ones( A.shape[-1] ) 
        self.A = A 
 
    def uncenter( self, x ): 
        return np.dot( self.A, x * self.std ) + np.dot( x, self.mean ) 
 
 
#............................................................................... 
if __name__ == "__main__": 
    import sys 
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    csv = "iris4.csv"  # wikipedia Iris_flower_data_set 
        # 5.1,3.5,1.4,0.2  # ,Iris-setosa ... 
    N = 1000 
    K = 20 
    fraction = .90 
    seed = 1 
    exec "\n".join( sys.argv[1:] )  # N= ... 
    np.random.seed(seed) 
    np.set_printoptions( 1, threshold=100, suppress=True )  # .1f 
    try: 
        A = np.genfromtxt( csv, delimiter="," ) 
        N, K = A.shape 
    except IOError: 
        A = np.random.normal( size=(N, K) )  # gen correlated ? 
 
    print "csv: %s  N: %d  K: %d  fraction: %.2g" % (csv, N, K, fraction) 
    Center(A) 
    print "A:", A 
 
    print "PCA ..." , 
    p = PCA( A, fraction=fraction ) 
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    print "npc:", p.npc 
    print "% variance:", p.sumvariance * 100 
 
    print "Vt[0], weights that give PC 0:", p.Vt[0] 
    print "A . Vt[0]:", dot( A, p.Vt[0] ) 
    print "pc:", p.pc() 
 
    print "\nobs <-> pc <-> x: with fraction=1, diffs should be ~ 0" 
    x = np.ones(K) 
    # x = np.ones(( 3, K )) 
    print "x:", x 
    pc = p.vars_pc(x)  # d' Vt' x 
    print "vars_pc(x):", pc 
    print "back to ~ x:", p.pc_vars(pc) 
 
    Ax = dot( A, x.T ) 
    pcx = p.obs(x)  # U' d' Vt' x 
    print "Ax:", Ax 
    print "A'x:", pcx 
    print "max |Ax - A'x|: %.2g" % np.linalg.norm( Ax - pcx, np.inf ) 
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    b = Ax  # ~ back to original x, Ainv A x 
    back = p.vars(b) 
    print "~ back again:", back 
    print "max |back - x|: %.2g" % np.linalg.norm( back - x, np.inf ) 
 
# end pca.py 
 
 
 
 
 
 
 
 
 
 
 
 
